artemether has been researched along with lumefantrine in 251 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (5.18) | 18.2507 |
| 2000's | 85 (33.86) | 29.6817 |
| 2010's | 126 (50.20) | 24.3611 |
| 2020's | 27 (10.76) | 2.80 |
| Authors | Studies |
|---|---|
| Annerberg, A; Aweeka, F; Clark, TD; Dorsey, G; Drysdale, T; German, P; Kalyango, JN; Kamya, MR; Lindegardh, N; McGee, B; Mwesigwa, J; Parikh, S; Rosenthal, PJ | 1 |
| Biamonte, MA; Le Roch, KG; Wanner, J | 1 |
| Brockman, A; Gathmann, I; Gemperli, B; Looareesuwan, S; Luxemburger, C; Nosten, F; Royce, C; Slight, T; van Vugt, M; White, NJ | 1 |
| Bojang, K; Doherty, T; Gathmann, I; Gemperli, B; Greenwood, B; Haywood, M; Jaffar, S; Jones, P; McAdam, K; Obaro, S; Pinder, M; Royce, C; Snounou, G; von Seidlein, L | 1 |
| Abdulla, S; Beck, HP; Gathmann, I; Hatz, C; Kibatala, P; Mull, R; Royce, C; Schellenberg, D; Tanner, M | 1 |
| Ezzet, F; Karbwang, J; Mull, R | 1 |
| Chalermrut, K; Chokejindachai, W; Gathmann, I; Gemperli, B; Looareesuwan, S; Royce, C; Wernsdorfer, W; Wilairatana, P | 1 |
| Mull, R; Skelton-Stroud, P | 1 |
| Cheng-Qi, S; Mull, R; Qing, JX; van Agtmael, MA; van Boxtel, CJ | 1 |
| Colussi, D; Lefèvre, G; Legay, F; Parisot, C | 1 |
| Ezzet, F; van Vugt, M; White, NJ | 1 |
| Björkman, A; Hassan Alin, M; Wernsdorfer, WH | 1 |
| Farkad, E; Karbwang, J; Mull, R; Na-Bangchang, K; Tasanor, U; Thanavibul, A | 1 |
| Ezzet, F; Gathmann, I; Looareesuwan, S; Nosten, F; van Vugt, M; White, NJ; Wilairatana, P | 1 |
| Ezzet, F; Looareesuwan, S; Nosten, F; van Vugt, M; White, NJ | 1 |
| Karbwang, J; Na-Bangchang, K; Tanariya, P; Tippawangkoso, P; Wernsdorfer, WH | 1 |
| Amakye, D; Carpenter, P; Lane, A; Lefèvre, G; Martin, JM; Schmidli, H; Souppart, C; Ward, C | 1 |
| Che, L; Dao, Q; He, W; Huang, D; Li, C; Li, X; Li, Z; Liu, X | 1 |
| Camus, D; Delhaes, L; Dutoit, E; Frealle, E | 1 |
| Kager, PA | 1 |
| Bricaire, F; Danis, M | 1 |
| Garner, P; Omari, AA; Preston, C | 1 |
| Brittenham, GM; Chalermrut, K; Kano, S; Krudsood, S; Looareesuwan, S; Pengruksa, C; Silachamroon, U; Srivilairit, S; Treeprasertsuk, S | 1 |
| Gamble, C; Garner, P; Omari, AA | 1 |
| Amklad, I; Looareesuwan, S; Rojanawatsirivej, C; Vijaykadga, S; Wilairatna, P | 1 |
| Barihuta, T; Barutwanayo, M; Bosman, A; Ciza, A; Delacollette, C; Kamana, J; Karenzo, J; Mizero, L; Moyou-Somo, R; Nahimana, A; Ndaruhutse, J; Ndayiragije, A; Niyungeko, D; Niyungeko, E; Nyarushatsi, JP; Ringwald, P | 1 |
| Bisoffi, Z; Depoortere, E; Guthmann, JP; Salvador, ET; Stivanello, E | 1 |
| Stingl, P | 1 |
| Wernsdorfer, WH | 1 |
| Annerberg, A; Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; White, NJ; Yapom, R | 1 |
| Ariey, F; Baur, F; Lepere, JF; Macarry, A; Rabarijaona, LP; Raharimalala, LA; Randrianarivelojosia, M; Receveur, MC; Robert, V; Roussin, C; Roussin, JM; Tall, A | 1 |
| Annerberg, A; Christophel, EM; Dittrich, S; Jelinek, T; Lindegardh, N; Monti, F; Phetsouvanh, R; Phompida, S; Stohrer, JM; Thongpaseuth, V; Vanisaveth, V | 1 |
| Bajunirwe, F; Biraro, S; Checchi, F; Fogg, C; Guthmann, JP; Kiguli, J; Kyomugisha, A; Musabe, J; Namiiro, P; Piola, P | 1 |
| Björkman, A; Gil, JP; Mårtensson, A; Msellem, M; Obondo, C; Sisowath, C; Strömberg, J | 1 |
| Bray, PG; Horrocks, P; Makanga, M; Ward, SA | 1 |
| Bangali, AM; Barends, M; Das, S; Faiz, AM; Kamal, M; Liem, L; Maung, UA; Peters, A; Rahman, M; Rahman, MR; van den Broek, IV | 1 |
| Garner, P; Jones, K; Taylor-Robinson, D | 1 |
| Hastings, IM; Ward, SA | 1 |
| Ali, AS; Björkman, A; Gil, JP; Mårtensson, A; Montgomery, SM; Msellem, MI; Olliaro, P; Sisowath, C; Strömberg, J | 1 |
| Ashley, EA; Brockman, A; Hutagalung, R; Jelinek, T; McGready, R; Nosten, FH; Paiphun, L; Singhasivanon, P; Thwai, KL; White, NJ | 1 |
| Allen, E; Barnes, KI; Bredenkamp, B; Dlamini, SS; Durrheim, DN; Jackson, A; Little, F; Mehta, U; Mthembu, DJ; Sharp, BL; Tsoka, J; White, NJ | 1 |
| Argaw, D; Babaniyi, O; Jima, D; Kebede, A; Medhin, A; Tesfaye, G | 1 |
| Balasegaram, M; Davidson, R; Dejene, S; Perkins, S; Tinnemann, P | 1 |
| Alecrim, MG; Alecrim, WD; Boulos, M; Cardoso, BS; Lacerda, MV; Mourão, MP; Padilha, A | 1 |
| Ahmed, OA; Elamin, SB; Eltaib, EH; Malik, EM; Mohamed, AO | 1 |
| Arunkamomkiri, J; Ashley, E; Carrara, VI; Htoo, H; Hutagalung, R; Nosten, F; Nwee, P; Singhasivanon, P; White, NJ; Zwang, J | 1 |
| Balkan, S; Checchi, F; Guerin, PJ; Guthmann, JP; Pinoges, L; Rolland, E | 1 |
| Anderson, TJ; Brockman, A; Hutagalung, R; Krishna, S; Nair, S; Nash, D; Nosten, F; Price, RN; Singhasivanon, P; Uhlemann, AC; van Vugt, M; White, NJ | 1 |
| Alaribe, A; Ejemot, R; Ekenjoku, J; Ezedinachi, E; Meremikwu, M; Nwachukwu, C; Ordu, D; Oyo-Ita, A | 1 |
| Andriano, K; De Palacios, PI; Falade, C; Hunt, P; Karbwang, J; Makanga, M; Mueller, EA; Premji, Z | 1 |
| Chinbuah, AM; Gyapong, JO; Gyapong, M; Pagnoni, F; Wellington, EK | 1 |
| Balkan, S; Cohuet, S; Fortes, F; Francis, M; Guthmann, JP; Kiguli, J; Kyomuhendo, J; Mulemba, M; Noël, F; Rigutto, C; Saraiva, N | 1 |
| Babigumira, J; Bajunirwe, F; Biraro, S; Checchi, F; Ferradini, L; Fogg, C; Grandesso, F; Guthmann, JP; Kigozi, I; Kiguli, J; Kyomuhendo, J; Piola, P; Ruzagira, E; Taylor, WR | 1 |
| Ahmed, ES; Elamin, SB; Elhassan, AH; Elmardi, KA; Malik, EM; Mannan, AA; Mohamed, TA; Mowien, RM | 1 |
| Toovey, S | 1 |
| Alecrim, Md; Alecrim, WD; Boulos, M; Cardoso, B; de Lacerda, MV; Mourão, MP; Padilha, A | 1 |
| Akhwale, W; Larson, BA; Snow, RW; Zurovac, D | 1 |
| Chalwe, V; Chilengi, R; D'Alessandro, U; Dujardin, JC; Moerman, F; Mulenga, M; Mwananyanda, L; Van Overmeir, C; VangGeertruyden, JP | 1 |
| Chanda, P; Hawela, M; Kango, M; Sipilanyambe, N | 1 |
| Chalwe, V; Chilengi, R; Colebunders, R; D'Alessandro, U; Dujardin, JC; Kasongo, W; Kestens, L; Moerman, F; Mulenga, M; Mwananyanda, L; Van Geertruyden, JP; Van Overmeir, C | 1 |
| Chappuis, F; Jackson, Y; Loutan, L; Taylor, W | 1 |
| Dicko, A; Djimde, A; Doumbo, OK; Fofana, M; Guindo, O; Jansen, HF; Kone, M; Ouattara, A; Sagara, I; Sissoko, M; Sogoba, M; Thera, MA; Tolo, Y | 1 |
| Ashley, EA; La, Y; Lindegardh, N; McGready, R; Nosten, F; Singhasivanon, P; Stepniewska, K; White, NJ | 1 |
| Al Attas, S; Balasegaram, M; Guthmann, JP; Kitz, C; Libama, F; van den Broek, I | 1 |
| Kokwaro, G; Mwai, L; Nzila, A | 1 |
| Ahmed, J; Hallett, RL; Humphreys, GS; Merinopoulos, I; Mutabingwa, TK; Sutherland, CJ; Whitty, CJ | 1 |
| Abdalli Mari, M; Ariey, F; Astafieva-Djaza, M; Gayibor, AH; Hafidhou, M; Moussa, M; Oumadi, A; Randrianarivelojosia, M; Ringwald, P; Said Ahmed, B; Said Ankili, A; Silai, R | 1 |
| Dokomajilar, C; Dorsey, G; Joloba, M; Nsobya, SL; Rosenthal, PJ | 1 |
| Dieng, Y; Faye, B; Faye, O; Gaye, O; Ndiaye, D; Ndiaye, JL | 1 |
| Kano, S; Krudsood, S; Looareesuwan, S; Luplertlop, N; Muangnoicharoen, S; Ringwald, P; Srivilairit, S; Tangpukdee, N; Thanachartwet, V; Wilairatana, P | 1 |
| Nyunt, MM; Plowe, CV | 1 |
| Agbodjan-Djossou, A; Azoumah, KD; Balaka, B; Djadou, D; Djadou, KE; Komlangan, A; Lawson-Evi, K | 1 |
| Berger, P; den, HJ; van Wout, JW; Visser, LG | 1 |
| Abdulla, S; Kabanywanyi, AM; Mandike, R; Mugittu, K; Mwita, A; Sumari, D | 1 |
| Hopkins, H; Lubell, Y; Mills, A; Staedke, SG; Whitty, CJ | 1 |
| Goodman, CA; Snow, RW; Wasunna, B; Zurovac, D | 1 |
| Ajanga, A; Amin, AA; Gitonga, CW; Kangwana, BB; Noor, AM; Snow, RW | 1 |
| Ademowo, OG; Falade, CO; Ladipo, SM; Ogundele, AO; Yusuf, BO | 1 |
| Bukirwa, H; Dorsey, G; Kamya, MR; Lugemwa, M; Rosenthal, PJ; Rwakimari, JB; Staedke, SG; Talisuna, A; Wabwire-Mangen, F; Yeka, A | 1 |
| Adedeji, AA; Balogun, T; Bolaji, OM; Fehintola, FA; Folarin, OA; Gbotosho, GO; Happi, CT; Sowunmi, A | 1 |
| Adjuik, M; Amenga-Etego, S; Asante, KP; Chandramohan, D; Dosoo, DK; Greenwood, B; Gyapong, J; Owusu, R; Owusu-Agyei, S | 1 |
| Andrade Nogueira, FH; Antônio Pianetti, G; César, Ida C | 1 |
| Bangali, AM; Day, NP; Dondorp, AM; Faiz, MA; Imwong, M; Kaewkungwal, J; Kamal, AT; Karim, J; Lindegardh, N; Rahman, MM; Singhasivanon, P | 1 |
| Christophel, E; Hu, XM; Lin, SG; Liu, J; Meng, F; Wang, GZ; Wang, SQ; Zeng, LH | 1 |
| Ashley, EA; Balkan, S; Bukirwa, H; Checchi, F; Dorsey, G; Guthmann, JP; Olliaro, P; Pinoges, L; Taylor, WR; Turyakira, E; Urruta, PP; van den Broek, I; van Herp, M; Zongo, I | 1 |
| Berens-Riha, N; Eshetu, T; Girma, T; Gürkov, R; Hempel, JM; Krause, E; Löscher, T; Mamo, Y; Miranda, IB; Schmidt, M | 1 |
| Meek, S; Nankabirwa, J; Njogu, JN; Rwakimari, JB; Snow, RW; Ssekitooleko, J; Talisuna, A; Tibenderana, JK; Zurovac, D | 1 |
| Coulibaly, M; Diallo, A; Diawara, SI; Dicko, A; Djimde, A; Doumbo, OK; Guindo, O; Kone, M; Maiga, H; Niambele, MB; Sagara, I; Sissoko, M | 1 |
| Davis, TM; Gomorrai, PS; Griffin, S; Ilett, KF; Karunajeewa, HA; Kotab, K; Lautu, D; Law, I; Lin, E; Mueller, I; Oa, O; Page-Sharp, M; Salman, S; Senn, M; Siba, P; Suano, P; Tarongka, N; Ura, A; Wong, R | 1 |
| Ashley, EA; Barends, M; Keereecharoen, L; Laochan, N; Lindegardh, N; McGready, R; Nosten, F; Phaiphun, L; Pimanpanarak, M; Singhasivanon, P; Tan, SO; Viladpai-Nguen, J; White, NJ; Wüstefeld, K | 1 |
| Dorsey, G; Nosten, F; Price, RN | 1 |
| Arens, TA; de Mast, Q; Druilhe, P; Hermsen, CC; Luty, AJ; Nieman, AE; Roestenberg, M; Sauerwein, RW; Swinkels, DW; van der Ven, AJ; van Dongen-Lases, EC | 1 |
| Banura, P; Jacob, ST; Kenya-Mugisha, N; Mayanja-Kizza, H; Meya, DB; Moore, CC; Pinkerton, R; Reynolds, SJ; Scheld, WM | 1 |
| Thompson, CA | 1 |
| Aweeka, FT; Charlebois, E; Dorsey, G; German, P; Hanpithakpong, W; Havlir, D; Lawrence, J; Lindegardh, N; Parikh, S; Rosenthal, PJ | 1 |
| Annerberg, A; Ashley, EA; Day, NP; Kamanikom, B; Lindegardh, N; McGready, R; Nosten, F; Pimanpanarak, M; Singhasivanon, P; Stepniewska, K; Tarning, J; White, NJ | 1 |
| Amos, B; Hendriksen, I; Mandea, V; Manjurano, A; Mapunda, E; Mrema, H; Mtove, G; Reyburn, H; Rutta, B; Sykes, A; Whitty, CJ | 1 |
| Bacchieri, A; Bassat, Q; Borrmann, S; Corsi, M; D'Alessandro, U; Menéndez, C; Mulenga, M; Nabasumba, C; Nambozi, M; Piola, P; Sasi, P; Talisuna, A; Tinto, H; Ubben, D; Valéa, I | 1 |
| de Mast, Q; Druilhe, P; Nieman, AE; Pop, G; Roestenberg, M; Sauerwein, R; Stalenhoef, A; van der Ven, A; Wiersma, J | 1 |
| Oguonu, T; Okafor, HU; Shu, EN | 1 |
| Dokomajilar, C; Greenhouse, B; Ouédraogo, JB; Rosenthal, PJ; Rouamba, N; Séré, YY; Somé, AF; Zongo, I | 1 |
| Nosten, FH | 1 |
| Bedu-Addo, G; Bhatt, KM; Borghini-Fuhrer, I; Bustos, DG; Duparc, S; Fleckenstein, L; Gaye, O; Kayentao, K; Sesay, SS; Shin, CS; Thompson, R; Tjitra, E; Tshefu, AK | 1 |
| Kano, S | 1 |
| Akter, J; Haque, R; Khan, WA; Ley, B; Marma, AS; Noedl, H; Starzengruber, P; Swoboda, P; Thriemer, K; Vossen, MG | 1 |
| Clark, TD; Dorsey, G; Greenhouse, B; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, SG | 1 |
| Annerberg, A; Ashton, M; Björkman, A; Dahlström, S; Färnert, A; Gil, P; Hietala, SF; Lindegårdh, N; Mårtensson, A; Ngasala, B; Premji, Z | 1 |
| Bellorio, KB; César, IC; Chellini, PR; de Abreu, FC; Moreira, JM; Pianetti, GA; Ribeiro, JA; Teixeira, Lde S | 1 |
| Abildrup, U; Alifrangis, LH; Alifrangis, M; Bygbjerg, IC; Hoegberg, L; Khalil, IF; Lemnge, MM; Maiga, D; Nyagonde, N; Persson, OP; Theander, TG; Vestergaard, LS | 1 |
| Arinaitwe, E; Bigira, V; Creek, D; Dorsey, G; Kakuru, A; Kamya, MR; Sandison, TG; Tappero, J; Wanzira, H | 1 |
| Khositnithikul, R; Mungthin, M; Na-Bangchang, K; Sitthichot, N; Suwandittakul, N; Ward, SA; Wattanaveeradej, V | 1 |
| Day, NP; Hanpithakpong, W; Kamanikom, B; Lindegardh, N; Singhasivanon, P; White, NJ | 1 |
| Davis, TM; Ilett, KF; Mueller, I; Salman, S; Siba, PM; Wong, RP | 1 |
| Cochupanachimootil, J; Harris, P; Norton, R; Price, S; Senthuran, S | 1 |
| Abdulla, S; Bassat, Q; Borrmann, S; Djimdé, AA; Lefèvre, G; Lyimo, J; Mandomando, I; Tekete, M | 1 |
| Faye, B; Faye, O; Kane, D; Kassi, KF; Kiki Barro, CP; Kone, M; Kuete, T; Menan, H; N'diaye, JL; Oga, AS; Same-Ekobo, A; Tine, R; Vicky, AM; Yavo, W | 1 |
| Anstey, NM; Chan, L; Donaldson, S; Frederick, C; Jelip, J; Khoo, S; Ma, G; Menon, J; Rajahram, G; William, T; Yeo, TW | 1 |
| Chin, LC; Fong, MY; Lau, YL; Noraishah, MA; Rohela, M; Tan, LH | 1 |
| Davis, TM; Griffin, S; Ilett, KF; Kose, K; Mueller, I; Page-Sharp, M; Salman, S; Siba, PM | 1 |
| Arguin, PM; Doney, AC; Galev, A; Green, M; Kapella, BK; Mekonnen, L; Phares, CR; Stauffer, WM; Weinberg, M | 1 |
| Denholm, J; Shortt, J; Smith, A; Spelman, D | 1 |
| Bashraheil, M; Bassat, Q; González, R; Kipkeu, C; Lefèvre, G; Lyimo, J; Machevo, S; Maiga, H; Mårtensson, A; Menéndez, C; Nahum, A; Nwaiwu, O; Ogutu, B; Ouma, P; Ubben, D; Walter, V | 1 |
| Franken, G; Häussinger, D; Holtfreter, MC; Labisch, A; Mehlhorn, H; Müller-Stöver, I; Richter, J; Walter, S | 1 |
| Chaudhry, AA; Khan, A; Khan, U | 1 |
| Kopel, E; Marhoom, E; Schwartz, E; Sidi, Y | 1 |
| Shanbag, P; Zaki, SA | 1 |
| Day, NP; Dhorda, M; Guerin, PJ; Kloprogge, F; Lindegardh, N; Muwanga, S; Nosten, F; Nuengchamnong, N; Piola, P; Tarning, J; Turyakira, E; White, NJ | 1 |
| García-Arieta, A; Gordon, J; Gwaza, L; Hansson, H; Potthast, H; Stahl, M; Welink, J | 1 |
| Córdoba, F; De la Hoz Restrepo, F; Porras Ramírez, A; Rico Mendoza, A; Rojas, DP | 1 |
| Balbiano, R; Calleri, G; Caramello, P | 1 |
| Achan, J; D'Alessandro, U; Talisuna, AO; Tibenderana, J; Yeka, A | 1 |
| Genton, B; Manong, D; Mueller, I; Rarau, P; Reeder, JC; Rogerson, SJ; Salib, M; Senn, N; Siba, P | 1 |
| Ogutu, B | 1 |
| DeMasi, R; Kakuda, TN; Mohammed, P; van Delft, Y | 1 |
| Beckman, DA; Butt, MT; Youreneff, M | 1 |
| Bracke, N; Burvenich, C; D'Hondt, M; De Spiegeleer, B; Duchateau, L; Peremans, K; Suleman, S; Vandercruyssen, K; Wynendaele, E | 1 |
| Back, DJ; Byakika-Kibwika, P; Hanpithakpong, W; Khoo, SH; Lamorde, M; Lefèvre, G; Mayito, J; Merry, C; Nabukeera, L; Ryan, M | 1 |
| Akinyi, S; Alemayehu, BH; Birhanu, SG; Demeke, L; Filler, S; Green, M; Hoos, D; Hwang, J; Jima, D; Kachur, SP; Kassa, M; Malone, JL; Melaku, Z; Nettey, H; Poe, A; Reithinger, R; Tekleyohannes, SG; Udhayakumar, V | 1 |
| Abdulla, S; Chemba, M; Juma, O; Marealle, IA; Minzi, OM; Ngaimisi, E; Rutaihwa, M; Sasi, P; Shekalaghe, S | 1 |
| Pathak, S; Patil, S; Patravale, V; Sharma, S; Suryavanshi, S | 1 |
| Dhorda, M; Guerin, PJ; Jullien, V; Kloprogge, F; Nosten, F; Piola, P; Tarning, J; White, NJ | 1 |
| Häussinger, D; Henrich, B; Holtfreter, MC; Imwong, M; Jensen, BO; Kocheril, SJ; MacKenzie, C; Mallach, S; Müller-Stöver, I; Orth, H; Richter, J; White, NJ | 1 |
| Burkholder, B; Bustos, MD; Delacollette, C; Wongsrichanalai, C | 1 |
| Enweji, N; Gheysari, F; Kaddumukasa, M; Kamugisha, E; Kironde, F; Sendagire, H; Swedberg, G | 1 |
| Agrawal, R; Khatri, PC; Kochar, DK; Lahoti, A; Tanwar, GS; Tanwar, P | 1 |
| Ademowo, OG; Dada-Adegbola, HO; Falade, CO; Nash, O; Oguike, MC; Ogunkunle, OO | 1 |
| Aditya, NP; Murthy, RS; Parashar, D | 1 |
| Adriko, M; Arinaitwe, M; Atuhaire, A; Betson, M; Kabatereine, NB; Mwesigwa, G; Nabonge, J; Sousa-Figueiredo, JC; Stothard, JR; Sutherland, CJ | 1 |
| Chen, T; Lu, T; Ma, Y; Mei, Q; Wang, Y; Zhao, W | 1 |
| Bruxvoort, K; Cairns, M; Festo, C; Goodman, C; Kachur, SP; Kalolella, A; Kenani, M; Lyaruu, P; Schellenberg, D | 1 |
| Adam, I; Ademowo, G; Arze, C; Baliraine, FN; Berens-Riha, N; Björkman, A; Borrmann, S; Checchi, F; Dahal, P; Davis, TME; Desai, M; Dhorda, M; Djimdé, AA; Dorsey, G; El-Sayed, BB; Eshetu, T; Eyase, F; Falade, C; Faucher, JF; Fröberg, G; Gadalla, NB; Grivoyannis, A; Guérin, P; Hamour, S; Houzé, S; Johnson, J; Kamugisha, E; Kariuki, S; Kiechel, JR; Kironde, F; Kofoed, PE; LeBras, J; Malmberg, M; Mårtensson, A; Ménard, D; Moriera, C; Mwai, L; Ngasala, B; Nosten, F; Nsanzabana, C; Nsobya, SL; Nzila, A; Oguike, M; Ogutu, B; Otienoburu, SD; Ouédraogo, JB; Piola, P; Plowe, CV; Price, RN; Rombo, L; Rosenthal, PJ; Schramm, B; Sibley, CH; Somé, AF; Stepniewska, K; Sutherland, CJ; Thwing, J; Ursing, J; Venkatesan, M; Wong, RPM; Zeynudin, A; Zongo, I | 1 |
| Adjei, GO; Alifrangis, M; Enweronu-Laryea, CC; Goka, BQ; Khalil, I; Kurtzhals, JA; Renner, L; Rodrigues, OP; Sulley, AM | 1 |
| Buza, J; Ishengoma, DS; Lemnge, MM; Mandara, CI; Shahada, F; Shayo, A | 1 |
| Äbelö, A; Ashton, M; Byakika-Kibwika, P; Day, NP; Hanpithakpong, W; Hoglund, RM; Lamorde, M; Merry, C; Tarning, J; White, NJ | 1 |
| Blagborough, AM; Brock, PM; Churcher, TS; Delves, MJ; Gething, PW; Ghani, AC; Leroy, D; Sala, KA; Sinden, RE; Upton, LM | 1 |
| Afizi, K; Fredrick, M; Kamya, MR; Lameyre, V; Lukwago, R; Talisuna, AO; Yeka, A | 1 |
| Hikasa, Y; Iguchi, A; Matsuu, A; Matsuyama, K | 1 |
| Benjamin, JM; Betuela, I; Bona, C; Davis, TM; Davis, WA; Karl, S; Kasian, B; Kattenberg, JH; Koleala, T; Laman, M; Lorry, L; Manning, L; Moore, BR; Mueller, I; Robinson, LJ; Rosanas-Urgell, A; Sambale, N; Siba, PM; Warrel, J; Yadi, G | 1 |
| Mannemala, SS; Nagarajan, JS | 1 |
| Diarra, A; Siribié, M; Sirima, SB; Soulama, I; Tiono, AB | 1 |
| Aklillu, E; Kamuhabwa, AA; Maganda, BA; Minzi, OM; Ngaimisi, E | 1 |
| Benjamin, J; Davis, TM; Ibam, C; Karl, S; Kasian, B; Koleala, T; Laman, M; Moore, BR; Mueller, I; Siba, PM; St Pierre, TG; Waltmann, A; Woodward, RC | 1 |
| Bassat, Q; Djimde, A; Hamed, K; Ogutu, B; Stricker, K | 1 |
| Djimde, AA; Hamed, K; Kuhen, K; Makanga, M | 1 |
| Duran, A; Sevim, E; Yalçın, M | 1 |
| Jones, C; Okiro, EA; Snow, RW; Todd, J; Wasunna, B; Webster, J | 1 |
| Adedeji, WA; Adewole, IF; Akinyinka, OO; Aweeka, FT; Darin, KM; Fehintola, F; Huang, L; Morse, GD; Murphy, RL; Olson, A; Parikh, S; Scarsi, KK; Taiwo, BO | 1 |
| Acheampong, PR; Antwi, GD; Bart Plange, C; Cairns, M; Chandramohan, D; Tagbor, H | 1 |
| Kakoko, D; Simba, D | 1 |
| Achan, J; Aweeka, F; Huang, L; Kajubi, R; Kiconco, S; Mwebaza, N; Mwima, MW; Nguyen, VK; Nyunt, MM; Parikh, S; Ssebuliba, J | 1 |
| Azandossessi, C; Damien, G; de Tove, YS; Kinde Gazard, D; Lawani, S; Ogouyèmi-Hounto, A; Remoue, F | 1 |
| Barnes, KI; Cohen, K; Kredo, T; Maartens, G; Mauff, K; Smith, PJ; Van der Walt, JS; Wiesner, L; Workman, L | 1 |
| Anvikar, AR; Arora, S; Bose, TK; Enosse, S; Gaye, O; Iyer, SS; Jalali, RK; Jha, AC; Kokolomami, J; Krudsood, S; Mohanty, R; Mohanty, S; Mwapasa, V; Ndiaye, JL; Noedl, H; Nyirenda, M; Rao, BHK; Rao, BS; Rao, D; Roy, A; Sagara, I; Saha, N; Sharma, P; Sidibe, B; Starzengruber, P; Swoboda, P; Tangpukdee, N; Thompson, R; Tiacoh, L; Toure, OA; Tshefu, AK; Valecha, N; Yumva, NN | 1 |
| Cohen, J; Kasozi, H; Saran, I; Yavuz, E | 1 |
| Bougouma, EC; Bousema, T; Bradley, J; Diarra, A; Drakeley, C; Eziefula, AC; Gonçalves, BP; Guelbéogo, WM; Lanke, K; Nebie, I; Ouédraogo, A; Pett, H; Siaka, D; Sirima, SB; Tiono, AB | 1 |
| Akhtar, A; Qadeer, A; Rasheed, A | 1 |
| Agbo, C; Agubata, O; Attama, A; Chime, S; Kenechukwu, F; Lovelyn, C; Ofokansi, K; Ogbonna, J; Umeyor, C | 1 |
| Adjei, S; Akwo-Kretchy, I; Ayeh-Kumi, P; Brock, B; Debrah, P; Hardlei, TF; Miltersen, KK; Nettey, H; Owusu-Danso, P; Petersen, E; Sarkodie, JA | 1 |
| Chen, A; Gallien, J; Leung, NH; Yadav, P | 1 |
| de Jager, C; Hongoro, C; Longwe, H; Mutero, CM; Mwendera, C; Phiri, K | 1 |
| Chavchich, M; Diagana, TT; Edstein, MD; Rowcliffe, K; Van Breda, K | 1 |
| Pathak, S; Patravale, V; Prabhu, P; Sharma, S; Suryavanshi, S | 1 |
| Chia, WN; Chotivanich, K; Goh, YS; Gruner, AC; Mayxay, M; Nosten, F; Peng, K; Preiser, P; Pukrittayakamee, S; Renia, L; Siau, A; Sriprawat, K; White, NJ | 1 |
| Ackermann, I; Aubin, F; Carn, G; Gesase, S; Lusingu, JPA; Mnkande, E; Mrango, Z; Mtoro, A; Ngocho, JS; Ogutu, B; Onyango, KO; Ouedraogo, A; Sirima, SB; Strub, N; Vanraes, J; Yaro, JB | 1 |
| Bélard, S; Damm, G; Kim, J; Kurth, F; Lingscheid, T; Mayer, B; Menner, N; Pongratz, P; Salama, A; Seehofer, D; Stegemann, MS; Steiner, F; Suttorp, N; von Bernuth, H; Zoller, T | 1 |
| Arinaitwe, E; Aweeka, FT; Bergqvist, Y; Bigira, V; Blessborn, D; Creek, DJ; Kakuru, A; McCormack, SA; Muhindo, M; Parikh, S; Sambol, NC; Sukumar, N; Tappero, JW; Tchaparian, E; Wanzira, H | 1 |
| Kong-Quee Iii, P; McKoy, MG; Pepple, DJ | 1 |
| Ahmed, I; ElMohammady, H; Jamil, M; Kakar, Q; Khan, MA; Sheikh, S; Warsame, M | 1 |
| Abdullahi, A; Affara, M; Ahouidi, AD; Coulibaly, M; D'Alessandro, U; Daniels, R; Deme, AB; Diakite, M; Diarra, A; Dieye, B; Dieye, T; Doumbia, S; Gomis, JF; Ismaela, A; Joof, F; Koita, O; Krogstad, DJ; Mbaye, A; Mbengue, B; Ndiaye, D; Ndiaye, JL; Ndiaye, M; Ndiaye, YD; Ngwa, AA; Nwakanma, D; Sangare, L; Shaffer, J; Sy, N; Volkman, SK; Welty, C; Wirth, DF | 1 |
| Kofoed, PE; Rodrigues, A; Rombo, L; Ursing, J | 1 |
| Allan, R; Floridia, M; Fortes, F; Lussiana, C; Martinho do Rosário, J | 1 |
| Bekkali, H; Belkouch, A; Belyamani, L; Jidane, S; Zidouh, S | 1 |
| Desai, P; Dhumatkar, R; Gaud, RS; Shende, P | 1 |
| Clark, RL; DeLise, AM; Youreneff, M | 1 |
| Amran, JG; Arale, AM; Barrette, A; Hassan, AH; Hassan, AM; Jibril, AM; Mohamud, SA; Muse, AY; Nada, RA; Warsame, M; Yusuf, FE | 1 |
| Abebe, Y; Billingsley, PF; Chakravarty, S; Diallo, H; Ding, K; Dolo, A; Doumbo, O; Duffy, PE; Fay, MP; Gabriel, EE; Guindo, MA; Gunasekera, A; Healy, SA; Hoffman, SL; James, ER; Kamate, B; Katile, A; Li, M; Manoj, A; Murshedkar, T; Niangaly, A; Niaré, K; Nutman, TB; O'Connell, EM; Omaswa, F; Richie, TL; Ruben, AJ; Samake, Y; Sim, BKL; Sissoko, K; Sissoko, MS; Thera, I; Walther, M; Wong-Madden, S; Zaidi, I; Zeguime, A | 1 |
| Genton, B; Hatz, C; Neumayr, A; Paris, DH | 1 |
| Ippolito, MM; Johnson, J; Li, T; Mallow, C; Morgan, N; Mullin, C; Rosenthal, PJ; Wallender, E | 1 |
| Assefa, A; Kassa, M; Mamo, H; Mohammed, H; Teklemariam, M | 1 |
| Álvarez-Larrotta, C; Aponte, S; Bernal, SD; González, C; Guerra, ÁP; Knudson-Ospina, A; Restrepo, C; Yasnot, MF | 1 |
| Chow, SC; Yuan, M; Zheng, J | 1 |
| Alonso, S; Munguambe, K; Sicuri, E | 1 |
| Ashton, M; Björkman, A; Gil, JP; Mårtensson, A; Ngasala, B; Piedade, R; Sciuto, CL; Vos, K | 1 |
| Nosten, F | 1 |
| van der Pluijm, RW; Watson, J; Woodrow, CJ | 1 |
| Sutherland, CJ | 1 |
| Aweeka, FT; Barlow-Mosha, L; Carey, V; Gingrich, D; Graham, B; Huang, L; Kamthunzi, P; Lindsey, JC; Marzan, F; Nachman, S; Parikh, S; Ssemambo, PK | 1 |
| Hasegawa, C; Kimura, M; Kudo, M; Maruyama, H | 1 |
| Ahmad, FJ; Ali, S; Imam, SS; Jain, GK; Rahman, MA; Raisuddin, S; Shakeel, K | 1 |
| Adegnika, AA; Agnandji, ST; Cattaneo, C; Endamne, L; Flohr, L; Groger, M; Kim, J; Klicpera, A; Kremsner, PG; Lalremruata, A; Matsiegui, PB; Mischlinger, J; Mombo-Ngoma, G; Mordmüller, B; Nguyen, T; Ramharter, M; Remppis, J; Veletzky, L; Zoleko-Manego, R | 1 |
| Akbulut, A; Akbulut, HH; Demirdağ, K; Gökmen Sevindik, Ö; Sağmak Tartar, A | 1 |
| Alifrangis, M; Baraka, V; Francis, F; Lutumba, P; Mavoko, HM; Nabasumba, C; Van Geertruyden, JP | 1 |
| Agarwal, P; Anvikar, AR; Pillai, CR; Srivastava, K | 1 |
| Bardinet, C; Buclin, T; Decosterd, LA; Gallay, J; Genton, B; Mercier, T; Pothin, E; Prod'hom, S; Spaggiari, D | 1 |
| Gao, H; Hou, S; Liu, H; Su, R; Sun, J; Yang, Y | 1 |
| César, IC; Fernandes, C; Pianetti, GA; Ricoy, LBM; Rivelli, GG | 1 |
| Gao, H; Kuang, X; Liu, H; Sun, J; Wang, Z; Yang, Y; Zhou, S | 1 |
| Bringmann, G; Feineis, D; Hoellein, L; Holzgrabe, U; Mufusama, JP; Ndjoko Ioset, K | 1 |
| Agaba, S; de Vries, PJ; Dorlo, TPC; Kaligirwa, N; Karlsson, MO; Lohy Das, J; Mens, PF; Rulisa, S; Tarning, J | 1 |
| Aina, OO; Ajibaye, OS; Amambua-Ngwa, A; Awandare, GA; Awolola, TS; Idowu, ET; Olukosi, YA; Otubanjo, OA; Oyebola, KM | 1 |
| Amara, A; Byakika-Kibwika, P; Chiong, J; Else, L; Gini, J; Kaboggoza, J; Khoo, SH; Lamorde, M; Tarning, J; Waitt, C; Walimbwa, SI; Winterberg, M | 1 |
| Abdel-Muhsin, AA; Abdelraheem, MH; Al Dhuhli, A; Al Hosni, A; Al Rubkhi, M; Al-Hamidhi, S; Babiker, HA; Bakhiet, AMA; Gadalla, A; Gismelseed, L; Kheir, A; Mukhtar, M; Naiem, A; Omer, S; Sultan, AA | 1 |
| Fungula, B; Inocencio da Luz, R; Kalabuanga, M; Lula Ntamba, Y; Lutumba, P; Muhindo Mavoko, H; Ntamabyaliro Nsengi, PM; Tona Lutete, G; Van Geertruyden, JP | 1 |
| Aweeka, F; Huang, L; Hughes, E; Kajubi, R; Mwebaza, N; Mwima, MW; Nguyen, V; Nyunt, MM; Orukan, F; Parikh, S | 1 |
| Atusiimirwe, JK; Ayikobua, ET; Kalange, M; Kasolo, J; Kasozi, KI; Matama, K; Munanura, EI; Namulema, J; Nansunga, M; Okpanachi, AO; Semuyaba, I; Ssempijja, F; Zirintunda, G | 1 |
| du Plessis, LH; Viljoen, JM; Wilkins, CA | 1 |
| Arenas Flores, A; Bautista Garcia, JE; Becerril Flores, MA; Gonzalez Alvarez, CM; González Linares, L; Imbert Palafox, JL; Reyes-Cruz, VE; Ruvalcaba Ledezma, JC | 1 |
| Alessandri, F; Angeletti, S; Bazzardi, R; Ceccarelli, G; Celani, L; Ciccozzi, M; D'Ettorre, G; De Angelis, M; Fontanelli Sulekova, L; Gabrielli, S; Lopalco, M; Mattiucci, S; Mazzocato, V; Pugliese, F; Ruberto, F; Spagnolello, O; Vita, S | 1 |
| Ahmed, FR; Habib, R; Khan, MZ; Saleem, T; Shoaib, MH; Siddiqui, F; Yousuf, RI | 1 |
| Rasmussen, C; Ringwald, P | 1 |
| Brisibe, A; Charlie-Silva, I; Costa, FTM; Donnelly, RF; Ferreira, LT; Figueiredo, MC; Foglio, MA; Kirkby, M; P Bonfanti, A; Paredes, AJ; Permana, AD; Raposo, C; Sousa, IMO; Volpe-Zanutto, F; Vora, LK | 1 |
| Davis, TME; Davis, WA; Hii, KC; Page-Sharp, M; Salman, S; Singh, B; Sugiarto, SR | 1 |
| Abla, N; Barber, BE; Barnes, KI; Boyle, MJ; Chalon, S; Chughlay, MF; El Gaaloul, M; Engwerda, CR; Griffin, P; Kress, A; Marquart, L; McCarthy, JS; Möhrle, JJ; Reuter, SE; Schultz, HB; Tapley, P; van Giersbergen, P; Webster, RA; Wells, T | 1 |
| Gustafsson, L; James, S; Thozhuthumparambil, KP; Zhang, Y | 1 |
| Fike, A; Hocaoğlu, M; Katz, JD; Rajasimhan, S; Schiffenbauer, A | 1 |
| Batty, KT; Bwire, GM; Davis, TME; Makani, J; Manning, L; Minzi, OMS; Moore, BR; Ngasala, B; Page-Sharp, M; Salman, S; Sugiarto, SR | 1 |
| Amambua-Ngwa, A; Bojang, F; D'Alessandro, U; Demba, MA; Diop, MF; Jeffries, D; Mane, K; Mbye, H; Mohammed, NI; Quashie, NB | 1 |
| Kamugisha, E; Konje, ET; Liwa, AC; Marwa, KJ; Mwita, S; Swedberg, G | 1 |
| Aweeka, FT; Colt, M; Goodwin, J; Huang, L; Kajubi, R; Li, F; Mwebaza, N; Orukan, F; Parikh, S; Richards, K; Wang, K; Whalen, ME | 1 |
| Callery, JJ; Chotthanawathit, P; Conradis-Jansen, F; Dondorp, AM; Duanguppama, J; Ean, M; Heng, C; Imwong, M; Jongdeepaisal, M; Khonputsa, P; Madmanee, W; Maude, RJ; Mukaka, M; Peerawaranun, P; Pell, C; Peto, TJ; Pongsoipetch, K; Rekol, H; Sokha, M; Sovannaroth, S; Soviet, U; Tarning, J; Tripura, R; von Seidlein, L; Waithira, N; White, NJ | 1 |
| Aweeka, F; Ehrlich, H; Freeman, T; French, J; Goodwin, J; Huang, L; Kajubi, R; Kay, K; Li, F; Mwebaza, N; Ou, J; Parikh, S; Riggs, M; Ruiz-Garcia, A; Wade, M; Wang, K | 1 |
| Abuaku, B; Afrane, Y; Amoah, LE; Cui, L; Duah-Quashie, NO; Duan, M; Huang, Y; Li, X; Pan, M; Qin, Y; Sun, K; Wang, X; Yang, Q; Yang, Z; Zeng, W; Zhao, H; Zhao, W; Zhou, L; Zhu, W | 1 |
| Adams, M; Buchwald, AG; Divala, TH; Earland, DE; Laufer, MK; Laurens, MB; Mallewa, JE; Miller, J; Mungwira, RG; Nampota-Nkomba, N; Nyangulu, W; Nyirenda, OM; Parikh, S; Plowe, CV; Taylor, TE; van Oosterhout, JJ | 1 |
| Adjei, GO; Ahorhorlu, SY; Alifrangis, M; Duah-Quashie, NO; Dzudzor, B; Hansson, H; Jensen, RW; Kudzi, W; Nartey, ET; Quashie, NB; Wang, CW; Zoiku, F | 1 |
| Chepngetich, J; Gachie, B; Gathirwa, J; Kiboi, D; Kimani, F; Magoma, G; Muriithi, B; Mwitari, P; Onchieku, N; Thiong'o, K | 1 |
| Buzibye, A; Nakalembe, L; Nsobya, S; Ocan, M; Omali, D; Otike, C | 1 |
| Amambua-Ngwa, A; Dugassa, S; Golassa, L; Jawara, A; Oboh, M; Oriero, E; Tadele, G | 1 |
| Chikoto, H; Csermak, K; Demin, I; El Gaaloul, M; Fofana, B; Grobusch, MP; Kaguthi, G; Kibuuka, A; Kusemererwa, S; Lingani, M; Lourenço, C; Marrast, AC; Mehta, D; Mombo-Ngoma, G; N'Guessan, TL; Nassa, GJW; Nduba, V; Nyantaro, M; Ogutu, B; Pathan, R; Risterucci, C; Singh, PK; Su, G; Thompson, R; Tina, LO; Tinto, H; Toure, AO; Uthaisin, C; Verma, A; Winnips, C; Yeka, A | 1 |
| Cai, J; Chen, G; Hu, G; Jin, L; Li, J; Li, Q; Li, S; Li, Y; Qian, J; Zhang, X; Zhou, Q | 1 |
| Angora, ÉK; Bedia-Tanoh, VA; Bosson-Vanga, H; Djohan, V; Kassi, FK; Kiki-Barro, PCM; Konaté-Touré, A; Koné-Bravo, EDM; Menan, HEI; Miezan, SAJ; Yavo, W | 1 |
19 review(s) available for artemether and lumefantrine
| Article | Year |
|---|---|
Recent advances in malaria drug discovery.
Topics: Animals; Antimalarials; Drug Discovery; Humans; Liver; Liver Transplantation; Malaria; Molecular Structure | 2013 |
Positioning, labelling, and medical information control of co-artemether tablets (CPG 56697): a fixed novel combination of artemether and benflumetol. Novartis Co-Artemether International Development Team.
Topics: Administration, Oral; Adolescent; Adult; Artemether; Artemisinins; Child; Child, Preschool; China; Drug Combinations; Drug Evaluation, Preclinical; Drug Industry; Drug Information Services; Drug Labeling; Drug Resistance; Ethanolamines; Fluorenes; Humans; International Cooperation; Lumefantrine; Malaria, Falciparum; Sesquiterpenes; Switzerland; Time Factors | 1998 |
Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethanolamines; Fluorenes; Food-Drug Interactions; Humans; Lumefantrine; Malaria; Plasmodium falciparum; Sesquiterpenes | 1999 |
[Three newly registered drugs in the Netherlands for the treatment and chemoprophylaxis of malaria: atovaquone-proguanil, artemether-lumefantrine and artemotil].
Topics: Antimalarials; Artemether; Artemisinins; Atovaquone; Drug Approval; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Naphthoquinones; Netherlands; Proguanil; Sesquiterpenes; Treatment Outcome | 2003 |
The new drug combinations: their place in the treatment of uncomplicated Plasmodium falciparum malaria.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Atovaquone; Drug Resistance, Multiple; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Naphthoquinones; Proguanil; Sesquiterpenes | 2003 |
Artemether-lumefantrine for treating uncomplicated falciparum malaria.
Topics: Antimalarials; Artemether; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Randomized Controlled Trials as Topic; Sesquiterpenes | 2003 |
Artemether-lumefantrine for uncomplicated malaria: a systematic review.
Topics: Antimalarials; Artemether; Artemisinins; Drug Administration Schedule; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Parasitemia; Randomized Controlled Trials as Topic; Sesquiterpenes; Treatment Outcome | 2004 |
[Malaria: prophylaxis, treatment, stand-by medication. A single mosquito bite suffices].
Topics: Adult; Antimalarials; Artemether; Artemisinins; Atovaquone; Chloroquine; Climate; Doxycycline; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Mefloquine; Naphthoquinones; Pregnancy; Proguanil; Risk Factors; Self Medication; Sesquiterpenes; Time Factors; Travel | 2004 |
Coartemether (artemether and lumefantrine): an oral antimalarial drug.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Sesquiterpenes | 2004 |
Malaria: uncomplicated, caused by Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Proguanil; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Ethanolamines; Female; Fever; Fluorenes; Humans; Infant; Life Cycle Stages; Lumefantrine; Malaria, Falciparum; Male; Time Factors | 2006 |
Artemether/lumefantrine in the treatment of uncomplicated falciparum malaria.
Topics: Artemether; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum | 2007 |
Artemisinin-based combination therapies and their introduction in Japan.
Topics: Animals; Antimalarials; Artemether; Artemisia annua; Artemisinins; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Japan; Lumefantrine; Malaria, Cerebral; Malaria, Falciparum; Mefloquine; Plasmodium falciparum | 2010 |
Artemether and lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.
Topics: Africa South of the Sahara; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Practice Guidelines as Topic; Treatment Outcome | 2013 |
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Quinolines | 2013 |
Tailoring a Pediatric Formulation of Artemether-Lumefantrine for Treatment of Plasmodium falciparum Malaria.
Topics: Antimalarials; Artemether; Artemisinins; Chemistry, Pharmaceutical; Clinical Trials, Phase III as Topic; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Randomized Controlled Trials as Topic; Tablets | 2015 |
The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.
Topics: Africa South of the Sahara; Antimalarials; Artemether; Artemisinins; Asia; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum | 2015 |
Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data.
Topics: Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Recurrence; Treatment Failure | 2015 |
The Relative Effects of Artemether-lumefantrine and Non-artemisinin Antimalarials on Gametocyte Carriage and Transmission of Plasmodium falciparum: A Systematic Review and Meta-analysis.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Culicidae; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Randomized Controlled Trials as Topic | 2017 |
92 trial(s) available for artemether and lumefantrine
| Article | Year |
|---|---|
Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Double-Blind Method; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Prospective Studies; Sesquiterpenes; Treatment Outcome | 1998 |
A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 1998 |
Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years.
Topics: Acute Disease; Administration, Oral; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Sesquiterpenes; Tanzania; Treatment Outcome | 1998 |
Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Double-Blind Method; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Middle Aged; Sesquiterpenes; Treatment Outcome | 1998 |
A randomized, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Double-Blind Method; Drug Administration Schedule; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Outcome Assessment, Health Care; Sesquiterpenes; Treatment Failure | 1999 |
Multiple dose pharmacokinetics of artemether in Chinese patients with uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; China; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Models, Chemical; Sesquiterpenes; Time Factors | 1999 |
Pharmacokinetics of benflumetol given as a fixed combination artemether-benflumetol (CGP 56697) in Thai patients with uncomplicated falciparum malaria.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Random Allocation; Sesquiterpenes; Thailand; Time Factors | 1999 |
No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Electrocardiography; Ethanolamines; Female; Fluorenes; Heart; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes | 1999 |
Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria.
Topics: Adult; Animals; Antimalarials; Area Under Curve; Artemether; Artemisinins; Biological Availability; Child; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Ethanolamines; Fluorenes; Food-Drug Interactions; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Prospective Studies; Sesquiterpenes; Treatment Outcome | 2000 |
Interaction trial between artemether-lumefantrine (Riamet) and quinine in healthy subjects.
Topics: Administration, Oral; Adult; Antimalarials; Artemether; Artemisinins; Drug Combinations; Drug Interactions; Drug Resistance, Multiple; Electrocardiography; Ethanolamines; Fluorenes; Humans; Infusions, Intravenous; Lumefantrine; Male; Middle Aged; Quinine; Sesquiterpenes | 2002 |
Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP) and artemether-lumefantrine (Coartem/Riamet) in the treatment of acute uncomplicated falciparum malaria in Thailand.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes; Thailand; Treatment Outcome; Trimethoprim | 2003 |
Monitoring the therapeutic efficacy of antimalarials against uncomplicated falciparum malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Primaquine; Sesquiterpenes; Statistics, Nonparametric; Thailand; Treatment Outcome | 2003 |
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Laos; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2004 |
Efficacy of artemether-lumefantrine treatment in patients with acute uncomplicated Falciparum malaria in Mayotte, a French collectivity of the Comoros Archipelago.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Comoros; Dose-Response Relationship, Drug; Drug Resistance; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Sesquiterpenes; Treatment Failure; Treatment Outcome | 2004 |
Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Biological Availability; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Korea; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sesquiterpenes; Treatment Outcome | 2004 |
In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem).
Topics: Alleles; Animals; Antimalarials; Artemether; Artemisinins; ATP-Binding Cassette Transporters; Child; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Genes, MDR; Humans; Infant; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Selection, Genetic; Sesquiterpenes | 2005 |
Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Artesunate; Bangladesh; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Odds Ratio; Plasmodium falciparum; Sesquiterpenes; Tanzania | 2005 |
A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Thailand | 2005 |
Successful treatment of Plasmodium falciparum malaria with a six-dose regimen of artemether-lumefantrine versus quinine-doxycycline in the Western Amazon region of Brazil.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Brazil; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Quinine | 2006 |
Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; ATP-Binding Cassette Transporters; Child; Child, Preschool; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins | 2006 |
Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2006 |
High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola.
Topics: Amodiaquine; Angola; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Sesquiterpenes; Treatment Outcome | 2006 |
Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Multivariate Analysis; Patient Compliance; Recurrence; Treatment Outcome; Uganda | 2006 |
Effects of weight, age, and time on artemether-lumefantrine associated ototoxicity and evidence of irreversibility.
Topics: Adult; Age Factors; Aged; Antimalarials; Artemether; Artemisinins; Audiometry; Body Weight; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Hearing Loss; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Mozambique; Time Factors; Treatment Outcome | 2006 |
Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Odds Ratio; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Zambia | 2006 |
Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Zambia | 2006 |
HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; CD4 Lymphocyte Count; Drug Combinations; Ethanolamines; Female; Fluorenes; HIV Infections; HIV-1; Humans; Immunosuppression Therapy; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome; Zambia | 2006 |
A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali.
Topics: Adolescent; Adult; Anemia; Antimalarials; Artemether; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sesquiterpenes; Sulfalene; Treatment Outcome | 2006 |
The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Area Under Curve; Artemether; Artemisinins; Drug Administration Schedule; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Half-Life; Humans; Lumefantrine; Malaria, Falciparum; Male; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Recurrence; Remission Induction; Sesquiterpenes; Tablets; Thailand | 2006 |
Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Democratic Republic of the Congo; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2006 |
Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child, Preschool; Drug Resistance; Ethanolamines; Female; Fluorenes; Genetic Linkage; Genotype; Haplotypes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Tanzania; Treatment Outcome | 2007 |
[Surveillance of falciparum malaria susceptibility to antimalarial drugs and policy change in the Comoros].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Clinical Protocols; Comoros; Consensus Development Conferences as Topic; Drug Combinations; Drug Resistance; Ethanolamines; Female; Fluorenes; Genotype; Health Policy; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Practice Guidelines as Topic; Public Health Administration; Recurrence; World Health Organization | 2007 |
Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Sesquiterpenes; Treatment Outcome; Uganda | 2007 |
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Senegal; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand.
Topics: Adolescent; Aged; Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Vivax; Male; Middle Aged; Parasitemia; Plasmodium vivax; Primaquine; Thailand; Treatment Outcome | 2007 |
Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Tanzania; Treatment Outcome | 2007 |
High efficacy of two artemisinin-based combinations (artemether-lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Treatment Outcome | 2008 |
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Policy; Humans; Infant; Lumefantrine; Malaria, Falciparum; Quinolines; Uganda | 2008 |
Activities of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine against sexual-stage parasites in falciparum malaria in children.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfalene; Survival Rate; Treatment Outcome | 2008 |
An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Dapsone; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Male; Polymerase Chain Reaction; Proguanil; Treatment Outcome | 2008 |
Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Directly Observed Therapy; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Medication Adherence; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Treatment Outcome | 2008 |
[Efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Hainan, China].
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; China; Dose-Response Relationship, Drug; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Quinolines; Treatment Outcome; Young Adult | 2008 |
Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial.
Topics: Adolescent; Adult; Artemether; Artemisinins; Atovaquone; Audiometry; Child; Ethanolamines; Ethiopia; Female; Fluorenes; Hearing Loss, Sensorineural; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Proguanil; Quinine | 2008 |
A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Base Sequence; DNA Primers; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mali; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Treatment Outcome | 2008 |
A trial of combination antimalarial therapies in children from Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Kaplan-Meier Estimate; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Male; Proportional Hazards Models; Pyrimethamine; Quinolines; Recurrence; Sulfadoxine | 2008 |
A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Thailand; Young Adult | 2008 |
Treatment of severe sepsis with artemether-lumefantrine is associated with decreased mortality in Ugandan patients without malaria.
Topics: Adult; Anti-Infective Agents; Artemether; Artemisinins; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Middle Aged; Prospective Studies; Sepsis; Uganda; Young Adult | 2009 |
Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Humans; Logistic Models; Lumefantrine; Malaria, Falciparum; Pregnancy; Young Adult | 2009 |
Azithromycin plus artesunate versus artemether-lumefantrine for treatment of uncomplicated malaria in Tanzanian children: a randomized, controlled trial.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Azithromycin; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fever of Unknown Origin; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Male; Tanzania; Treatment Outcome | 2009 |
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial.
Topics: Africa; Antiparasitic Agents; Artemether; Artemisinins; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Time Factors | 2009 |
Therapeutic efficacy and effect on gametocyte carriage of an artemisinin and a non-based combination treatment in children with uncomplicated P. falciparum malaria, living in an area with high-level chloroquine resistance.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Gametogenesis; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfalene; Treatment Outcome | 2010 |
Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemether; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Naphthyridines; Treatment Outcome; Young Adult | 2010 |
Azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh: an open-label randomized, controlled clinical trial.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Azithromycin; Bangladesh; Child; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Time Factors; Treatment Outcome; Young Adult | 2010 |
Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Incidence; Infant; Lumefantrine; Malaria; Male; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2010 |
Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania.
Topics: Antimalarials; Artemether; Artemisinins; Body Temperature; Child; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Tanzania; Treatment Outcome | 2010 |
Increased risk of early vomiting among infants and young children treated with dihydroartemisinin-piperaquine compared with artemether-lumefantrine for uncomplicated malaria.
Topics: Antimalarials; Artemether; Artemisinins; Child, Preschool; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Quinolines; Risk; Uganda; Vomiting | 2010 |
Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria.
Topics: Antimalarials; Artemether; Artemisinins; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male | 2011 |
Comparative study of the efficacy and tolerability of dihydroartemisinin-piperaquine-trimethoprim versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Cameroon; Child; Child, Preschool; Cote d'Ivoire; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Quinolines; Senegal; Treatment Outcome; Trimethoprim; Young Adult | 2011 |
Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male | 2011 |
Similar efficacy and safety of artemether-lumefantrine (Coartem®) in African infants and children with uncomplicated falciparum malaria across different body weight ranges.
Topics: Age Factors; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Body Weight; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Time Factors; Treatment Outcome | 2011 |
Statistical approaches to indirectly compare bioequivalence between generics: a comparison of methodologies employing artemether/lumefantrine 20/120 mg tablets as prequalified by WHO.
Topics: Adult; Antimalarials; Area Under Curve; Artemether; Artemisinins; Biological Availability; Cross-Over Studies; Data Interpretation, Statistical; Drugs, Generic; Ethanolamines; Fluorenes; Humans; Lumefantrine; Male; Therapeutic Equivalency | 2012 |
Artesunate + amodiaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in the Colombian Pacific region: a noninferiority trial.
Topics: Adult; Amodiaquine; Antimalarials; Artemether; Artemisinins; Colombia; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Treatment Outcome | 2012 |
Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children.
Topics: Antimalarials; Artemether; Artemisinins; Child, Preschool; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Quinine; Quinolines; Safety; Treatment Outcome; Uganda | 2013 |
Effectiveness of artemether/lumefantrine for the treatment of uncomplicated Plasmodium vivax and P. falciparum malaria in young children in Papua New Guinea.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Child, Preschool; Ethanolamines; Fluorenes; Humans; Infant; Kaplan-Meier Estimate; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Papua New Guinea; Prospective Studies; Treatment Outcome | 2013 |
Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial.
Topics: Adult; Anti-HIV Agents; Antimalarials; Artemether; Artemisinins; Cross-Over Studies; Darunavir; Drug Interactions; Ethanolamines; Fluorenes; Healthy Volunteers; HIV; HIV Infections; Humans; Lumefantrine; Malaria; Middle Aged; Nitriles; Pyridazines; Pyrimidines; Ritonavir; Sulfonamides | 2013 |
In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Ethanolamines; Ethiopia; Female; Fluorenes; Genotype; Humans; Infant; Lumefantrine; Malaria, Vivax; Male; Middle Aged; Parasitemia; Plasmodium vivax; Primaquine; Prospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2013 |
Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator's product.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Biological Availability; Cross-Over Studies; Drugs, Generic; Ethanolamines; Fluorenes; Humans; Lumefantrine; Male; Tablets; Tanzania; Therapeutic Equivalency; Young Adult | 2013 |
Evaluation of the comparative efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine and artesunate-amodiaquine-chlorpheniramine (Artemoclo™) for the treatment of acute uncomplicated malaria in Nigerian children.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chlorpheniramine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Genome, Protozoan; Humans; Infant; Lumefantrine; Malaria; Male; Nigeria; Polymerase Chain Reaction | 2014 |
Cluster randomized trial of text message reminders to retail staff in tanzanian drug shops dispensing artemether-lumefantrine: effect on dispenser knowledge and patient adherence.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Commerce; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria; Male; Patient Compliance; Plasmodium; Tanzania; Text Messaging | 2014 |
A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria.
Topics: Amodiaquine; Anemia, Sickle Cell; Antimalarials; Artemether; Artemisinins; Blood Cell Count; Child; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Ghana; Hemoglobins; Humans; Lumefantrine; Malaria, Falciparum; Parasite Load; Survival Analysis | 2014 |
Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in North-Eastern Tanzania.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Tanzania; Treatment Outcome | 2014 |
Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implications.
Topics: Adult; Aged; Anti-HIV Agents; Antimalarials; Artemether; Artemisinins; Biological Availability; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Interactions; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Male; Middle Aged; Models, Biological; Young Adult | 2015 |
Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Child, Preschool; Data Collection; Drug Combinations; Ethanolamines; Female; Fever; Fluorenes; Hemoglobins; Humans; Infant; Insecticide-Treated Bednets; Lumefantrine; Malaria, Falciparum; Male; Parasite Load; Patient Compliance; Safety; Splenomegaly; Treatment Outcome; Uganda | 2014 |
Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged | 2014 |
Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Chemoprevention; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Ghana; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria; Male; Pyrimethamine; Quinolines; Rain; Seasons; Sulfadoxine | 2016 |
Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Cohort Studies; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Middle Aged; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Treatment Outcome; Uganda; Young Adult | 2015 |
Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Benin.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Benin; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male | 2016 |
The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients.
Topics: Adult; Anti-HIV Agents; Artemether; Artemisinins; Drug Interactions; Ethanolamines; Female; Fluorenes; HIV Infections; HIV-1; Humans; Lopinavir; Lumefantrine; Male; Ritonavir | 2016 |
A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether-Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and Africa.
Topics: Adolescent; Adult; Africa; Aged; Antimalarials; Artemether; Artemisinins; Asia; Child; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Half-Life; Heterocyclic Compounds, 1-Ring; Humans; India; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Peroxides; Plasmodium falciparum; Quinolines; Spiro Compounds; Young Adult | 2016 |
Can Rapid Diagnostic Testing for Malaria Increase Adherence to Artemether-Lumefantrine?: A Randomized Controlled Trial in Uganda.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Medication Adherence; Point-of-Care Testing; Uganda | 2016 |
Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial.
Topics: Antimalarials; Artemether; Artemisinins; Asymptomatic Infections; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Prevalence; Primaquine | 2016 |
Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
Topics: Africa South of the Sahara; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Patient Safety; Polymerase Chain Reaction | 2016 |
Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.
Topics: Antimalarials; Artemether; Artemisinins; Black People; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Recurrence; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda | 2016 |
Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Children Aged Less than 15 Years in Guinea-Bissau - An Open-Label Non-Inferiority Randomised Clinical Trial.
Topics: Antimalarials; Artemether; Artemisinins; Child; Ethanolamines; Fluorenes; Guinea-Bissau; Humans; Lumefantrine; Malaria, Falciparum; Quinolines; Treatment Outcome | 2016 |
Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Double-Blind Method; Ethanolamines; Female; Fluorenes; Humans; Immunization Schedule; Lumefantrine; Malaria, Falciparum; Male; Mali; Plasmodium falciparum; Vaccination | 2017 |
Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Democratic Republic of the Congo; Drug Combinations; Ethanolamines; Fluorenes; Haplotypes; Humans; Lumefantrine; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Uganda | 2018 |
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Coadministered Ruxolitinib and Artemether-Lumefantrine in Healthy Adults.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Nitriles; Pyrazoles; Pyrimidines; Single-Blind Method; Young Adult | 2022 |
The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Malaria, Falciparum; Parasitemia; Prospective Studies; Reinfection; Uganda | 2023 |
Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Cambodia; Chemoprevention; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum | 2023 |
Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; HIV Infections; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malawi; Treatment Outcome | 2023 |
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Child; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum; Treatment Outcome | 2023 |
140 other study(ies) available for artemether and lumefantrine
| Article | Year |
|---|---|
Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.
Topics: Amodiaquine; Antimalarials; Area Under Curve; Artemether; Artemisinins; Artesunate; Biotransformation; Body Weight; Child; Child, Preschool; Chromatography, Liquid; Drug Combinations; Ethanolamines; Female; Fluorenes; Half-Life; Humans; Longitudinal Studies; Lumefantrine; Male; Spectrophotometry, Ultraviolet; Uganda | 2010 |
Binding of artemether and lumefantrine to plasma proteins and erythrocytes.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Blood Proteins; Dogs; Erythrocytes; Ethanolamines; Fluorenes; Humans; Lumefantrine; Mice; Protein Binding; Rabbits; Rats; Sesquiterpenes; Ultrafiltration | 1999 |
Synergism of benflumetol and artemether in Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Culture Media; Drug Resistance, Multiple; Drug Synergism; Ethanolamines; Fluorenes; Inhibitory Concentration 50; Lumefantrine; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes | 1999 |
In vitro sensitivity of Plasmodium falciparum and clinical response to lumefantrine (benflumetol) and artemether.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Sesquiterpenes | 2000 |
[Observation on efficacy of artemether compound against vivax malaria].
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; Lumefantrine; Malaria, Vivax; Male; Middle Aged; Recurrence; Sesquiterpenes | 1999 |
[Riamet: a new antimalarial for curative treatment of malaria].
Topics: Antimalarials; Artemether; Artemisinins; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Prognosis; Sesquiterpenes | 2002 |
[Efficacy of therapeutic combinations with artemisinin derivatives in the treatment of non complicated malaria in Burundi].
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Burundi; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Rural Health; Sesquiterpenes; Treatment Failure; Urban Health; Vomiting | 2004 |
Adherence to a combination of artemether and lumefantrine (Coartem) in Kajo Keji, southern Sudan.
Topics: Antimalarials; Artemether; Artemisinins; Child, Preschool; Dietary Fats; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Patient Compliance; Sesquiterpenes; Sudan; Treatment Outcome | 2004 |
Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda.
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Patient Compliance; Plasmodium falciparum; Risk Factors; Self Administration; Sesquiterpenes; Surveys and Questionnaires; Uganda | 2004 |
Towards a proteomic definition of CoArtem action in Plasmodium falciparum malaria.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Electrophoresis, Gel, Two-Dimensional; Ethanolamines; Fluorenes; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Proteomics; Reverse Transcriptase Polymerase Chain Reaction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2005 |
Coartem (artemether-lumefantrine) in Africa: the beginning of the end?
Topics: Africa; Animals; Antimalarials; Artemether; Artemisinins; ATP-Binding Cassette Transporters; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mutation; Plasmodium falciparum; Protozoan Proteins | 2005 |
Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa.
Topics: Adolescent; Adult; Animals; Anopheles; Antimalarials; Artemether; Artemisinins; Child; Community Health Services; Drug Administration Schedule; Drug Combinations; Ethanolamines; Female; Fluorenes; Health Policy; Humans; Insect Vectors; Lumefantrine; Malaria, Falciparum; Male; Mosquito Control; Patient Compliance; Retrospective Studies; Rural Health Services; South Africa; Surveys and Questionnaires | 2005 |
Safety and efficacy of artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Ethiopia.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Ethiopia; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Prospective Studies; Safety; Treatment Outcome | 2005 |
Examples of tropical disease control in the humanitarian medical programmes of MSF and Merlin.
Topics: Antimalarials; Artemether; Artemisinins; Attitude to Health; Child; Child, Preschool; Communicable Disease Control; Cross Infection; Eflornithine; Ethanolamines; Ethiopia; Female; Fluorenes; Humans; Lassa Fever; Lumefantrine; Malaria; Medical Missions; Pregnancy; Sierra Leone; Sudan; Trypanocidal Agents; Trypanosomiasis, African; Tuberculosis, Pulmonary; USSR | 2006 |
The efficacies of artesunate-sulfadoxine-pyrimethamine and artemether-lumefantrine in the treatment of uncomplicated, Plasmodium falciparum malaria, in an area of low transmission in central Sudan.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Prospective Studies; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Outcome | 2006 |
A case-control auditory evaluation of patients treated with artemether-lumefantrine.
Topics: Acoustic Impedance Tests; Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Audiometry; Case-Control Studies; Child; Drug Therapy, Combination; Ethanolamines; Evoked Potentials, Auditory, Brain Stem; Female; Fluorenes; Hearing Loss; Humans; Lumefantrine; Malaria; Male; Middle Aged; Treatment Outcome | 2006 |
Operational response to malaria epidemics: are rapid diagnostic tests cost-effective?
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Cost-Benefit Analysis; Diagnostic Tests, Routine; Disease Outbreaks; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Health Care Costs; Humans; Lumefantrine; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Sensitivity and Specificity; Sesquiterpenes | 2006 |
Feasibility and acceptability of the use of artemether-lumefantrine in the home management of uncomplicated malaria in children 6-59 months old in Ghana.
Topics: Antimalarials; Artemether; Artemisinins; Caregivers; Child, Preschool; Clinical Competence; Community Health Services; Drug Administration Schedule; Drug Combinations; Ethanolamines; Feasibility Studies; Female; Fluorenes; Ghana; Home Nursing; Humans; Infant; Lumefantrine; Malaria; Male; Patient Acceptance of Health Care; Patient Compliance | 2006 |
From chloroquine to artemisinin-based combination therapy: the Sudanese experience.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria, Falciparum; Product Surveillance, Postmarketing; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Time Factors | 2006 |
First Brazilian experience with the use of artemether-lumefantrine (Coartem) a fixed-dosed ACT combination.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Brazil; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Time Factors; World Health Organization | 2006 |
The financial and clinical implications of adult malaria diagnosis using microscopy in Kenya.
Topics: Adolescent; Adult; Anti-Infective Agents; Antimalarials; Artemether; Artemisinins; Diagnostic Errors; Ethanolamines; Fever; Fluorenes; Health Care Costs; Humans; Kenya; Lumefantrine; Malaria; Microscopy; Models, Economic; Prevalence; Sensitivity and Specificity | 2006 |
Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure?
Topics: Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Cote d'Ivoire; Dose-Response Relationship, Drug; Drug Labeling; Ethanolamines; Female; Fluorenes; Guidelines as Topic; Guinea; Humans; Lactones; Lumefantrine; Malaria, Falciparum; Parasitemia; Recurrence; Risk; Sesquiterpenes; Sudan; Switzerland; Treatment Failure; World Health Organization | 2006 |
Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Design; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Global Health; Half-Life; Humans; Lumefantrine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Proguanil; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2007 |
[Artemether-lumefantrine, treatment of child more than 5 years old uncomplicated malaria in Tsevie's hospital (Togo)].
Topics: Antimalarials; Artemether; Artemisinins; Child; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Safety | 2007 |
[Treatment of falciparum malaria with artemether-lumefantrine according to a 5-day schedule: results of a study in 21 patients and recommendations].
Topics: Adult; Aged; Antimalarials; Artemether; Artemisinins; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Ethanolamines; Feces; Female; Fluorenes; Humans; Length of Stay; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Parasite Egg Count; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome | 2007 |
An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria.
Topics: Adolescent; Adult; Animals; Antigens, Protozoan; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Cost-Benefit Analysis; Costs and Cost Analysis; Decision Support Techniques; Decision Trees; Diagnostic Tests, Routine; Ethanolamines; Fluorenes; Humans; L-Lactate Dehydrogenase; Lumefantrine; Malaria; Plasmodium; Protozoan Proteins; Sensitivity and Specificity; Uganda; Urban Population | 2008 |
Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Case Management; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Government Programs; Guideline Adherence; Health Personnel; Humans; Kenya; Lumefantrine; Malaria; Male; Middle Aged; Rural Population; Surveys and Questionnaires | 2008 |
The use of artemether-lumefantrine by febrile children following national implementation of a revised drug policy in Kenya.
Topics: Anti-Infective Agents; Antimalarials; Artemether; Artemisinins; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Drug Therapy, Combination; Ethanolamines; Fever; Fluorenes; Health Policy; Humans; Infant; Infant, Newborn; Kenya; Lumefantrine; Rural Health | 2008 |
Simultaneous determination of artemether and lumefantrine in fixed dose combination tablets by HPLC with UV detection.
Topics: Antimalarials; Artemether; Artemisinins; Chromatography, High Pressure Liquid; Dosage Forms; Drug Combinations; Ethanolamines; Fluorenes; Lumefantrine; Molecular Structure; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tablets | 2008 |
Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children.
Topics: Africa; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Databases as Topic; Drug Combinations; Ethanolamines; Fluorenes; Genotype; Humans; Infant; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
Malaria case-management under artemether-lumefantrine treatment policy in Uganda.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Cross-Sectional Studies; Ethanolamines; Fluorenes; Guideline Adherence; Health Policy; Health Services Research; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria; Middle Aged; Uganda | 2008 |
Antimalarial therapies in children from Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Biological Availability; Drug Therapy, Combination; Ethanolamines; Fats; Fluorenes; Humans; Lumefantrine; Malaria; Quinolines; Treatment Failure | 2009 |
Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection.
Topics: Adult; Antimalarials; Antimicrobial Cationic Peptides; Artemether; Artemisinins; Biomarkers; C-Reactive Protein; Cell Count; Erythrocytes; Ethanolamines; Female; Ferritins; Fluorenes; Hemoglobins; Hepcidins; Homeostasis; Humans; Interleukin-6; Iron; Iron, Dietary; Linear Models; Lumefantrine; Malaria, Falciparum; Male; Parasitemia; Reticulocytes; Young Adult | 2009 |
First artemisinin-based antimalarial combination approved for U.S. market.
Topics: Administration, Oral; Antimalarials; Artemether; Artemisinins; Drug Approval; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Tablets; United States; United States Food and Drug Administration | 2009 |
Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers.
Topics: Adult; Antimalarials; Area Under Curve; Artemether; Artemisinins; Cytochrome P-450 CYP3A; Drug Interactions; Ethanolamines; Female; Fluorenes; HIV Protease Inhibitors; Humans; Lopinavir; Lumefantrine; Male; Middle Aged; Pyrimidinones; Ritonavir | 2009 |
Cardiac complication after experimental human malaria infection: a case report.
Topics: Acute Coronary Syndrome; Adult; Animals; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Human Experimentation; Humans; Insect Bites and Stings; Lumefantrine; Malaria Vaccines; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Treatment Outcome; Vaccination | 2009 |
Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Burkina Faso; Drug Combinations; Drug Resistance, Bacterial; Ethanolamines; Fluorenes; Genotype; Humans; Infant; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Recurrence; Sulfadoxine | 2010 |
Pyronaridine-artesunate for uncomplicated falciparum malaria.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Naphthyridines | 2010 |
Liquid chromatography-tandem mass spectrometry for the simultaneous quantitation of artemether and lumefantrine in human plasma: application for a pharmacokinetic study.
Topics: Acetates; Acetic Acid; Antimalarials; Artemether; Artemisinins; Calibration; Chromatography, Liquid; Ethanolamines; Fluorenes; Formates; Humans; Lumefantrine; Methanol; Models, Chemical; Quality Control; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2011 |
Measurement of lumefantrine and its metabolite in plasma by high performance liquid chromatography with ultraviolet detection.
Topics: Acetates; Artemether; Artemisinins; Calibration; Chemistry Techniques, Analytical; Chromatography; Chromatography, High Pressure Liquid; Ethanolamines; Fluorenes; Hexanes; Kinetics; Lumefantrine; Models, Chemical; Phenanthrenes; Regression Analysis; Reproducibility of Results; Spectrophotometry, Ultraviolet; Ultraviolet Rays | 2011 |
Association between the pfmdr1 gene and in vitro artemether and lumefantrine sensitivity in Thai isolates of Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemether; Artemisinins; DNA Fingerprinting; DNA, Protozoan; Drug Resistance; Ethanolamines; Fluorenes; Inhibitory Concentration 50; Lumefantrine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Thailand | 2010 |
A liquid chromatographic-tandem mass spectrometric method for determination of artemether and its metabolite dihydroartemisinin in human plasma.
Topics: Antimalarials; Artemether; Artemisinins; Calibration; Chromatography, Liquid; Drug Therapy, Combination; Ethanolamines; Fluorenes; High-Throughput Screening Assays; Humans; Lumefantrine; Malaria, Falciparum; Reproducibility of Results; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2009 |
Desbutyl-lumefantrine is a metabolite of lumefantrine with potent in vitro antimalarial activity that may influence artemether-lumefantrine treatment outcome.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Drug Combinations; Drug Interactions; Ethanolamines; Fluorenes; Lumefantrine; Plasmodium falciparum | 2011 |
Automated erythrocytapheresis for severe falciparum malaria.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Australia; Automation; Blood Component Removal; Cambodia; Combined Modality Therapy; Drug Therapy, Combination; Erythrocyte Transfusion; Erythrocytes; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Parasitemia; Travel | 2011 |
Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia.
Topics: Acute Kidney Injury; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Ethanolamines; Female; Fluorenes; Hospitals, Urban; Humans; Lumefantrine; Malaria; Malaysia; Microscopy; Middle Aged; Parasitemia; Patient Selection; Plasmodium knowlesi; Polymerase Chain Reaction; Quinine; Respiratory Distress Syndrome; Severity of Illness Index; Shock; Survival Rate | 2011 |
Plasmodium knowlesi reinfection in human.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Blood Transfusion; Doxycycline; Ethanolamines; Fluorenes; Hemolysis; Humans; Lumefantrine; Malaria; Malaysia; Male; Mefloquine; Microscopy; Phylogeny; Plasmodium knowlesi; Polymerase Chain Reaction; Protozoan Proteins; Quinine; Recurrence | 2011 |
Presumptive treatment to reduce imported malaria among refugees from east Africa resettling in the United States.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Pyrimethamine; Refugees; Sulfadoxine; Tanzania; United States | 2011 |
Plasmodium species co-infection as a cause of treatment failure.
Topics: Antimalarials; Artemether; Artemisinins; Australia; Coinfection; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Plasmodium malariae; Travel; Treatment Outcome; Uganda | 2011 |
Why do Plasmodium malariae infections sometimes occur in spite of previous antimalarial medication?
Topics: Adult; Animals; Antibodies, Protozoan; Antimalarials; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Plasmodium falciparum; Plasmodium malariae | 2012 |
Falciparum--the masquerader.
Topics: Antimalarials; Artemether; Artemisinins; Biopsy; Bone Marrow; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Platelet Transfusion; Purpura, Thrombocytopenic; Treatment Outcome; Young Adult | 2012 |
Successful oral therapy for severe falciparum malaria: the World Health Organization criteria revisited.
Topics: Administration, Oral; Adult; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Retrospective Studies; Treatment Outcome; World Health Organization; Young Adult | 2012 |
Increased urinary frequency: an unusual presentation of Plasmodium falciparum malaria.
Topics: Antimalarials; Artemether; Artemisinins; Child; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Urination Disorders | 2012 |
Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Chromatography; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mass Spectrometry; Models, Statistical; Plasma; Pregnancy; Pregnancy Complications, Infectious; Uganda; Young Adult | 2012 |
Are artemisinin-based combination therapies effective against Plasmodium malariae?
Topics: Adult; Antimalarials; Artemether; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; HIV Infections; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium malariae; Treatment Failure | 2013 |
Neurotoxicity assessment of artemether in juvenile rats.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Body Weight; Dose-Response Relationship, Drug; Ethanolamines; Female; Fluorenes; Kinetics; Lumefantrine; Male; Neurotoxicity Syndromes; No-Observed-Adverse-Effect Level; Rats; Rats, Wistar; Toxicity Tests | 2013 |
A rapid stability-indicating, fused-core HPLC method for simultaneous determination of β-artemether and lumefantrine in anti-malarial fixed dose combination products.
Topics: Antimalarials; Artemether; Artemisinins; Chromatography, High Pressure Liquid; Drug Stability; Ethanolamines; Fluorenes; Humans; Lumefantrine; Quality Control; Technology, Pharmaceutical; Time Factors | 2013 |
Lower artemether, dihydroartemisinin and lumefantrine concentrations during rifampicin-based tuberculosis treatment.
Topics: Adult; Antimalarials; Antitubercular Agents; Artemether; Artemisinins; Drug Antagonism; Ethanolamines; Female; Fluorenes; HIV Infections; Humans; Longitudinal Studies; Lumefantrine; Male; Rifampin; Tuberculosis; Uganda | 2013 |
Evaluation of novel lipid based formulation of β-Artemether and Lumefantrine in murine malaria model.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chemistry, Pharmaceutical; Disease Models, Animal; Ethanolamines; Fluorenes; Lipids; Lumefantrine; Malaria; Male; Mice; Parasitemia; Plasmodium berghei | 2013 |
Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
Topics: Adolescent; Adult; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Pregnancy; Quinine; Young Adult | 2013 |
Plasmodium knowlesi infection imported to Germany, January 2013.
Topics: Acute Kidney Injury; Antimalarials; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Germany; Humans; Lumefantrine; Malaria; Microscopy; Middle Aged; Plasmodium knowlesi; Polymerase Chain Reaction; Thailand; Travel; Treatment Outcome | 2013 |
Detecting adenosine triphosphatase 6 (pfATP6) point mutations that may be associated with Plasmodium falciparum resistance to artemisinin: prevalence at baseline, before policy change in Uganda.
Topics: Anti-Infective Agents; Artemether; Artemisinins; Calcium-Transporting ATPases; Drug Resistance, Microbial; Drug Therapy, Combination; Ethanolamines; Fluorenes; Genotype; Humans; Lumefantrine; Malaria, Falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; Sequence Analysis, DNA; Uganda | 2011 |
Hemophagocytic syndrome associated with severe Plasmodium vivax malaria in a child in Bikaner (northwestern India).
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Biopsy, Needle; Bone Marrow; Child; Ethanolamines; Female; Fluorenes; Humans; India; Liver Function Tests; Lumefantrine; Lymphohistiocytosis, Hemophagocytic; Malaria, Vivax; Plasmodium vivax; Primaquine; Schizonts; Treatment Outcome | 2013 |
Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Drug Carriers; Ethanolamines; Fluorenes; Lipids; Lumefantrine; Malaria; Mice; Nanostructures; Particle Size; Plasmodium berghei | 2016 |
Detection of persistent Plasmodium spp. infections in Ugandan children after artemether-lumefantrine treatment.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Coinfection; Diagnostic Tests, Routine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; Longitudinal Studies; Lumefantrine; Malaria; Male; Plasmodium; Plasmodium falciparum; Plasmodium ovale; Point-of-Care Systems; Prevalence; Uganda | 2014 |
Enhanced antimalarial activity by a novel artemether-lumefantrine lipid emulsion for parenteral administration.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Emulsions; Ethanolamines; Female; Fluorenes; Lumefantrine; Malaria; Male; Mice; Plasmodium berghei | 2014 |
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
Topics: Amino Acid Substitution; Amodiaquine; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Datasets as Topic; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Genetic Markers; Genotype; Humans; Infant; Kaplan-Meier Estimate; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Risk Factors | 2014 |
Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations.
Topics: Adamantane; Animals; Anopheles; Antimalarials; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Indoles; Insect Vectors; Lumefantrine; Malaria; Mice; Peroxides; Plasmodium berghei; Primaquine; Spiro Compounds | 2015 |
The efficacy of artemisinin, artemether, and lumefantrine against Babesia gibsoni in vitro.
Topics: Anti-Infective Agents; Artemether; Artemisinins; Atovaquone; Babesia; Drug Resistance; Ethanolamines; Fluorenes; Lumefantrine | 2015 |
Development and validation of a generic liquid chromatographic method for the simultaneous determination of five commonly used antimalarial drugs: Application to pharmaceutical formulations and human plasma.
Topics: Antimalarials; Artemether; Artemisinins; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Ethanolamines; Fluorenes; Healthy Volunteers; Humans; Lumefantrine; Mefloquine; Pyrimethamine; Reproducibility of Results; Sulfadoxine; Tablets | 2015 |
[Effect of a large scale community-based distribution of artemether-lumefantrine on its therapeutic efficacy among children living in a rural area of Burkina Faso].
Topics: Antimalarials; Artemether; Artemisinins; Burkina Faso; Child, Preschool; Delivery of Health Care; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Male; Population Density; Randomized Controlled Trials as Topic; Rural Population; Sample Size; Treatment Outcome | 2015 |
CYP2B6*6 genotype and high efavirenz plasma concentration but not nevirapine are associated with low lumefantrine plasma exposure and poor treatment response in HIV-malaria-coinfected patients.
Topics: Alkynes; Anti-HIV Agents; Antimalarials; Artemether; Artemisinins; ATP Binding Cassette Transporter, Subfamily B; Benzoxazines; Case-Control Studies; Coinfection; Cyclopropanes; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Drug Antagonism; Drug Therapy, Combination; Ethanolamines; Fluorenes; Genotype; HIV Infections; Humans; Lumefantrine; Malaria; Nevirapine; Prospective Studies | 2016 |
Gametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination Therapy.
Topics: Antimalarials; Artemether; Artemisinins; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Half-Life; Humans; Kinetics; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Male; Naphthoquinones; Plasmodium falciparum | 2015 |
[Treated with Artemether-Lumefantrine Five Evaluation of P. Falciparum Malaria Cases in Terms of Hyponatremia and Thrombocytopenia].
Topics: Adult; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Hyponatremia; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Severity of Illness Index; Thrombocytopenia; Time Factors; Treatment Outcome; Young Adult | 2015 |
The Impact of a Community Awareness Strategy on Caregiver Treatment Seeking Behaviour and Use of Artemether-Lumefantrine for Febrile Children in Rural Kenya.
Topics: Antimalarials; Artemether; Artemisinins; Awareness; Caregivers; Child, Preschool; Community Health Services; Community Participation; Cross-Sectional Studies; Ethanolamines; Family Characteristics; Female; Fever; Fluorenes; Humans; Infant; Infant, Newborn; Kenya; Lumefantrine; Malaria; Male; Patient Acceptance of Health Care | 2015 |
Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral Therapy.
Topics: Adult; Anti-HIV Agents; Antimalarials; Artemether; Artemisinins; Case-Control Studies; Coinfection; Drug Combinations; Drug Interactions; Ethanolamines; Female; Fluorenes; HIV Infections; HIV-1; Humans; Lumefantrine; Malaria, Falciparum; Male; Nevirapine; Nigeria; Plasmodium falciparum | 2015 |
Access to subsidized artemether-lumefantrine from the private sector among febrile children in rural setting in Kilosa, Tanzania.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fever; Fluorenes; Health Services Accessibility; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria; Male; Private Sector; Rural Population; Surveys and Questionnaires; Tanzania | 2012 |
Severe acute respiratory distress syndrome secondary to Plasmodium vivax malaria.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Vivax; Male; Radiography, Thoracic; Respiration, Artificial; Respiratory Distress Syndrome | 2016 |
Formulation design, in vitro characterizations and anti-malarial investigations of artemether and lumefantrine-entrapped solid lipid microparticles.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Biological Availability; Drug Delivery Systems; Drug Design; Ethanolamines; Fluorenes; Lipids; Lumefantrine; Mice; Microspheres; Particle Size; Solubility | 2016 |
Artemether-Lumefantrine Concentrations in Tablets and Powders from Ghana Measured by a New High-Performance Liquid Chromatography Method.
Topics: Antimalarials; Artemether; Artemisinins; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Compounding; Ethanolamines; Fluorenes; Ghana; Lumefantrine; Powders; Reproducibility of Results; Tablets | 2016 |
The Impact of Inventory Management on Stock-Outs of Essential Drugs in Sub-Saharan Africa: Secondary Analysis of a Field Experiment in Zambia.
Topics: Antimalarials; Artemether; Artemisinins; Delivery of Health Care; Drugs, Essential; Ethanolamines; Fluorenes; Health Facilities; Health Planning; Humans; Lumefantrine; Malaria; Materials Management, Hospital; Models, Statistical; Pharmaceutical Services; Plasmodium falciparum; Workforce | 2016 |
Malaria research and its influence on anti-malarial drug policy in Malawi: a case study.
Topics: Antimalarials; Artemether; Artemisinins; Biomedical Research; Chloroquine; Drug Combinations; Drug Resistance; Ethanolamines; Evidence-Based Medicine; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malawi; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2016 |
The Spiroindolone KAE609 Does Not Induce Dormant Ring Stages in Plasmodium falciparum Parasites.
Topics: Antimalarials; Artemether; Artemisinins; Drug Resistance; Erythrocytes; Ethanolamines; Fluorenes; Humans; Indoles; Inhibitory Concentration 50; Life Cycle Stages; Lumefantrine; Plasmodium falciparum; Rhodamine 123; Spiro Compounds | 2016 |
Artemether-lumefantrine nanostructured lipid carriers for oral malaria therapy: Enhanced efficacy at reduced dose and dosing frequency.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Carriers; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lipids; Lumefantrine; Malaria; Male; Mice; Nanostructures; Plasmodium berghei; Rats; Rats, Wistar; Treatment Outcome | 2016 |
Neutralizing Antibodies against Plasmodium falciparum Associated with Successful Cure after Drug Therapy.
Topics: Acute Disease; Adolescent; Adult; Antibodies, Neutralizing; Antibodies, Protozoan; Antibody Specificity; Antigens, Protozoan; Antimalarials; Artemether; Artemisinins; Azithromycin; Cohort Studies; Erythrocytes; Ethanolamines; Female; Fluorenes; Humans; Immune Sera; Immunity, Humoral; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Protozoan Proteins; Recurrence; Treatment Outcome | 2016 |
Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria.
Topics: Administration, Oral; Adolescent; Adult; Anemia; Antimalarials; Artemether; Artemisinins; Child; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Hemolysis; Humans; Lumefantrine; Malaria, Falciparum; Male; Prospective Studies; Quinolines | 2016 |
In vitro effects of co-incubation of blood with artemether/lumefantrine & vitamin C on the viscosity & elasticity of blood.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Ascorbic Acid; Blood Viscosity; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; In Vitro Techniques; Lumefantrine; Malaria, Falciparum | 2016 |
Efficacy of artemisinin-based combination therapies for the treatment of falciparum malaria in Pakistan (2007-2015): In vivo response and dhfr and dhps mutations.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria, Falciparum; Male; Mutation; Pakistan; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Sulfadoxine | 2016 |
West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia.
Topics: Adolescent; Amino Acid Sequence; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Resistance; Ethanolamines; Fluorenes; Follow-Up Studies; Gambia; Genetic Loci; Humans; Lumefantrine; Malaria, Falciparum; Mali; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Senegal; Young Adult | 2016 |
Impact of introducing subsidized combination treatment with artemether-lumefantrine on sales of anti-malarial monotherapies: a survey of private sector pharmacies in Huambo, Angola.
Topics: Angola; Antimalarials; Artemether; Artemisinins; Drug Costs; Drug Therapy, Combination; Ethanolamines; Financing, Government; Fluorenes; Health Services Accessibility; Humans; Lumefantrine; Malaria; Marketing of Health Services; Pharmacies; Private Sector | 2016 |
Spontaneous splenic rupture from Plasmodium ovalae malaria.
Topics: Abdomen; Adult; Africa, Central; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Endemic Diseases; Ethanolamines; Fluorenes; Humans; Laparoscopy; Lumefantrine; Malaria; Male; Plasmodium ovale; Splenectomy; Splenic Rupture; Tomography, X-Ray Computed | 2017 |
Engineering of microcomplex of artemether and lumefantrine for effective drug treatment in malaria.
Topics: Antimalarials; Artemether; Artemisinins; beta-Cyclodextrins; Citric Acid; Drug Carriers; Drug Interactions; Drug Liberation; Ethanolamines; Fluorenes; Lumefantrine; Malaria; Microspheres; Particle Size; Pyrrolidines; Vinyl Compounds | 2017 |
Developmental toxicity studies of lumefantrine and artemether in rats and rabbits.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Embryonic Development; Ethanolamines; Female; Fetal Development; Fluorenes; Lumefantrine; Malaria, Falciparum; Male; Maternal Exposure; Pregnancy; Rabbits; Rats; Rats, Sprague-Dawley; Toxicity Tests; Toxicokinetics | 2016 |
Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Dihydropteroate Synthase; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Prospective Studies; Protozoan Proteins; Pyrimethamine; Somalia; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2017 |
Artemether-Lumefantrine Treatment Failure in Nonimmune European Travelers With Plasmodium falciparum Malaria: Do We Need to Reconsider Dosing in Patients From Nonendemic Regions?
Topics: Artemether; Humans; Lumefantrine; Malaria, Falciparum; Retrospective Studies; Sweden; Treatment Failure | 2017 |
Therapeutic efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in a high-transmission area in northwest Ethiopia.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; DNA, Protozoan; Drug Combinations; Ethanolamines; Ethiopia; Female; Fluorenes; Follow-Up Studies; Headache; Hemoglobins; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Prospective Studies; Treatment Outcome; World Health Organization; Young Adult | 2017 |
Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Colombia; DNA Copy Number Variations; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Young Adult | 2017 |
On assessing bioequivalence and interchangeability between generics based on indirect comparisons.
Topics: Anti-HIV Agents; Antimalarials; Artemether; Artemisinins; Computer Simulation; Confidence Intervals; Drugs, Generic; Ethanolamines; Fluorenes; HIV Infections; Humans; Lamivudine; Lumefantrine; Malaria; Models, Statistical; Therapeutic Equivalency; Zidovudine | 2017 |
Market for Artemether-Lumefantrine to treat childhood malaria in a district of southern Mozambique.
Topics: Antimalarials; Artemether; Child; Child, Preschool; Drug Therapy, Combination; Female; Financing, Personal; Health Services Needs and Demand; Humans; Infant; Lumefantrine; Malaria; Male; Mozambique; Outcome Assessment, Health Care; Regression Analysis | 2017 |
MRP2/ABCC2 C1515Y polymorphism modulates exposure to lumefantrine during artemether-lumefantrine antimalarial therapy.
Topics: Antimalarials; Area Under Curve; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Genotype; Humans; Lumefantrine; Malaria, Falciparum; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Tissue Distribution | 2017 |
[Elimination in South-East Asia? The role of antimalarial drugs].
Topics: Antimalarials; Artemether; Artemisinins; Asia, Southeastern; Disease Eradication; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Quinolines | 2016 |
Antimalarial Resistance Unlikely To Explain U.K. Artemether-Lumefantrine Failures.
Topics: Antimalarials; Artemether; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Lumefantrine; Malaria, Falciparum | 2017 |
Reply to van der Pluijm et al., "Antimalarial Resistance Unlikely To Explain U.K. Artemether-Lumefantrine Failures".
Topics: Antimalarials; Artemether; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Lumefantrine; Malaria, Falciparum | 2017 |
Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.
Topics: Africa South of the Sahara; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Male; Nevirapine | 2017 |
Severe delayed haemolytic anaemia associated with artemether-lumefantrine treatment of malaria in a Japanese traveller.
Topics: Administration, Intravenous; Administration, Oral; Anemia, Hemolytic; Antimalarials; Artemether; Artemisinins; Artesunate; Blackwater Fever; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Plasmodium vivax; Recurrence; Young Adult | 2018 |
Development and in vitro/in vivo evaluation of artemether and lumefantrine co-loaded nanoliposomes for parenteral delivery.
Topics: Animals; Antimalarials; Artemether; Drug Liberation; Liposomes; Lumefantrine; Malaria; Mice; Nanoparticles; Tissue Distribution | 2019 |
Prospective Clinical Trial Assessing Species-Specific Efficacy of Artemether-Lumefantrine for the Treatment of Plasmodium malariae, Plasmodium ovale, and Mixed Plasmodium Malaria in Gabon.
Topics: Adolescent; Adult; Antimalarials; Artemether; Child; Child, Preschool; Female; Gabon; Humans; Lumefantrine; Male; Plasmodium malariae; Plasmodium ovale; Young Adult | 2018 |
A Case of Severe Plasmodium falciparum Malaria Co-Infected with HIV Improved with Exchange Transfusion.
Topics: Adult; Africa South of the Sahara; Antimalarials; Artemether; Artemisinins; Coinfection; Diagnosis, Differential; Erythrocyte Transfusion; Ethanolamines; Fluorenes; HIV Infections; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Severity of Illness Index; Travel; Turkey | 2017 |
Topics: Anti-Bacterial Agents; Antimalarials; Artemether; Artemisinins; Atovaquone; Azithromycin; Chloroquine; Doxycycline; Ethanolamines; Fluorenes; Humans; India; Lumefantrine; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 2017 |
LC-MS/MS method for the simultaneous analysis of seven antimalarials and two active metabolites in dried blood spots for applications in field trials: Analytical and clinical validation.
Topics: Antimalarials; Artemether; Artemisinins; Chromatography, Liquid; Dried Blood Spot Testing; Ethanolamines; Fluorenes; Humans; Lumefantrine; Plasma; Reproducibility of Results; Tandem Mass Spectrometry; Temperature | 2018 |
A sensitive, high-throughput, and ecofriendly method for the determination of lumefantrine, artemether, and its active metabolite dihydroartemisinin by supercritical fluid chromatography and tandem mass spectrometry.
Topics: Animals; Artemether; Artemisinins; Chromatography, Supercritical Fluid; Ethanolamines; Fluorenes; Lumefantrine; Male; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Tandem Mass Spectrometry | 2018 |
Level A in vitro-in vivo correlation: Application to establish a dissolution test for artemether and lumefantrine tablets.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Middle Aged; Solubility; Tablets; Young Adult | 2018 |
Optimization and evaluation of lipid emulsions for intravenous co-delivery of artemether and lumefantrine in severe malaria treatment.
Topics: Administration, Intravenous; Animals; Antimalarials; Artemether; Biological Availability; Drug Delivery Systems; Emulsions; Lumefantrine; Malaria; Male; Particle Size; Rats | 2018 |
Quality of the antimalarial medicine artemether - lumefantrine in 8 cities of the Democratic Republic of the Congo.
Topics: Antimalarials; Artemether; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Congo; Drug Contamination; Drug Stability; Humans; Lumefantrine; Malaria; Quality Control | 2018 |
Population Pharmacokinetics of Artemether, Dihydroartemisinin, and Lumefantrine in Rwandese Pregnant Women Treated for Uncomplicated Plasmodium falciparum Malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Female; Humans; Lumefantrine; Malaria, Falciparum; Pregnancy; Tandem Mass Spectrometry; Young Adult | 2018 |
A barcode of multilocus nuclear DNA identifies genetic relatedness in pre- and post-Artemether/Lumefantrine treated Plasmodium falciparum in Nigeria.
Topics: Adolescent; Adult; Aged; Alleles; Antimalarials; Artemether; Child; Child, Preschool; Dihydropteroate Synthase; DNA Barcoding, Taxonomic; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Mutation; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Young Adult | 2018 |
Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine.
Topics: Adult; Amodiaquine; Antimalarials; Artemether; Artesunate; Breast Feeding; Cross-Over Studies; Drug Interactions; Female; Heterocyclic Compounds, 3-Ring; Humans; Lumefantrine; Male; Oxazines; Piperazines; Pyridones | 2019 |
Evolution of Plasmodium falciparum drug resistance genes following artemisinin combination therapy in Sudan.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; DNA, Protozoan; Drug Resistance; Drug Therapy, Combination; Genetic Markers; Genotype; Humans; Lumefantrine; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sudan; Sulfadoxine | 2019 |
Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo.
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child, Preschool; Clindamycin; Democratic Republic of the Congo; Drug Combinations; Female; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Quinine | 2019 |
Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Interactions; Female; HIV Infections; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Pregnancy; Prospective Studies; Uganda; Young Adult | 2020 |
Antimalarial combination therapies increase gastric ulcers through an imbalance of basic antioxidative-oxidative enzymes in male Wistar rats.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artesunate; Drug Therapy, Combination; Gastric Mucosa; Glutathione; Indomethacin; Inflammation; Lumefantrine; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Stomach Ulcer | 2020 |
Characterization of solid lipid dispersions prepared by hot fusion containing a double-fixed dose combination of artemether and lumefantrine.
Topics: Antimalarials; Artemether; Lipids; Lumefantrine; Prospective Studies; Solubility; Tablets | 2020 |
In vitro redox activity of haemozoin and β-haemozoin interacting with the following antimalarials: artemether, lumefantrine and quinine.
Topics: Animals; Antimalarials; Artemether; Electrodes; Hemiptera; Hemoglobins; Humans; Lumefantrine; Oxidation-Reduction; Particle Size; Quinine; Surface Properties | 2020 |
Malaria in an asylum seeker paediatric liver transplant recipient: diagnostic challenges for migrant population.
Topics: Antimalarials; Artemether; Artesunate; Child, Preschool; Humans; Liver Transplantation; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Transients and Migrants; Transplant Recipients; Treatment Outcome | 2021 |
HPLC-UV method for simultaneous quantitation of artemether and lumefantrine in fixed dose combination orodispersible tablet formulation.
Topics: Acetonitriles; Administration, Oral; Artemether; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Lumefantrine; Tablets; Trifluoroacetic Acid | 2020 |
Continued Low Efficacy of Artemether-Lumefantrine in Angola?
Topics: Angola; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Lumefantrine | 2021 |
Artemether and lumefantrine dissolving microneedle patches with improved pharmacokinetic performance and antimalarial efficacy in mice infected with Plasmodium yoelii.
Topics: Animals; Antimalarials; Artemether; Female; Lumefantrine; Malaria, Falciparum; Mice; Mice, Inbred C57BL; Plasmodium yoelii | 2021 |
The pharmacokinetic properties of artemether and lumefantrine in Malaysian patients with Plasmodium knowlesi malaria.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Male; Middle Aged; Plasmodium knowlesi | 2022 |
Fatal case of delayed-onset haemolytic anaemia after oral artemether-lumefantrine.
Topics: Anemia, Hemolytic; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Middle Aged | 2021 |
Report of a Homeopathic Medication Regimen Containing Artemether/Lumefantrine in a Patient With Rheumatoid Arthritis.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Arthritis, Rheumatoid; Humans; Lumefantrine | 2021 |
The effect of sickle cell genotype on the pharmacokinetic properties of artemether-lumefantrine in Tanzanian children.
Topics: Anemia, Sickle Cell; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Ethanolamines; Fluorenes; Genotype; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Tanzania | 2022 |
Plasmodium falciparum merozoite invasion ligands, linked antimalarial resistance loci and ex vivo responses to antimalarials in The Gambia.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Resistance; Gambia; Ligands; Lumefantrine; Malaria; Malaria, Falciparum; Merozoites; Plasmodium falciparum; Protozoan Proteins | 2022 |
Lumefantrine plasma concentrations in uncontrolled conditions among patients treated with artemether-lumefantrine for uncomplicated plasmodium falciparum malaria in Mwanza, Tanzania.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Tanzania; Treatment Outcome | 2022 |
Impact of Drug Exposure on Resistance Selection Following Artemether-Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Fluorenes; HIV Infections; Humans; Lopinavir; Lumefantrine; Malaria; Malaria, Falciparum; Nevirapine; Ritonavir; Uganda | 2023 |
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Ghana; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine | 2022 |
Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Drug Tolerance; Ghana; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum | 2023 |
Prevalence of mutations in the cysteine desulfurase IscS (Pfnfs1) gene in recurrent Plasmodium falciparum infections following artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) treatment in Matayos, Western Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Humans; Kenya; Lumefantrine; Malaria; Malaria, Falciparum; Mutation; Plasmodium falciparum; Prevalence; Quinolines; Reinfection | 2023 |
Pharmacopeial quality of artemether-lumefantrine anti-malarial agents in Uganda.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Uganda | 2023 |
Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Drug Resistance; Ethiopia; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins | 2023 |
Determine the enzymatic kinetic characteristics of CYP3A4 variants utilizing artemether-lumefantrine.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cytochrome P-450 CYP3A; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Molecular Docking Simulation | 2023 |
Knowledge and practices of private pharmacy auxiliaries on malaria in Abidjan, Côte d'Ivoire.
Topics: Antimalarials; Artemether; Cote d'Ivoire; Cross-Sectional Studies; Drug Combinations; Female; Humans; Lumefantrine; Malaria; Pharmacies; Pharmacy; Pregnancy; Surveys and Questionnaires | 2023 |